Marketing the use of the space environment for the processing of biological and pharmaceutical materials by unknown
(NASA-CE-176334) MARKETING TEE USE OF THE
	 N86-12243
SPACE ENVIRONMENT FOR THE PfiGCESSING OF
BIOLOGICAL AND PHABEACEUTICAL MATERIALS
Final Report (ECGN, Inc.)	 162 p	 Unclas
HC A08/MF A01	 CSCL 22A G3/12 16237
^ it-3 by
MARKE"iING THE USE OF THE
SPACE ENVIRONMENT FOR THE
PROCESSING OF BIOLOGICAL AND
PHARMACEUTICAL MATERIALS
FINAL REPORT
https://ntrs.nasa.gov/search.jsp?R=19860002776 2020-03-20T15:51:47+00:00Z
TV
81-110	 ^^ ^^
O^
MARKETING THE USE OF THE SPACE ENVIRONMENT FOR THE
PROCESSING OF BIOLOGICAL AND PHARMACEUTICAL MATERIALS U( tW
0`^
Final Report 
Ec%^;,nINCOPP RATED
Prepared for
The National Aeronautics and Space Administration
NASA HEADQUARTERS
Prepared under
Contract Number NASW-3339
Prepared by	
Y,
ECON, Inc.
April 13, 1984
i
ABSTRACT
This study examines the perceptions of U.S. biotechnology and pharma-
ceutical companies concerning the potential use of the space environment for the
processing of biological substances. Physical phenomena that may be important in
space-based processing of biological materials are identified and discussed in the
context of past and current experiment programs. The capabilities of NASA to
support future research and development, and to engage in cooperative risk sharing
programs with industry are discussed. Meetings were held with several
biotechnology and pharmaceutical companies to provide data for an analysis of the
attitudes and perceptions of these industries toward the use of the space
environment. Recommendations are made for actions that might be taken by
NASA to facilitate the marketing of the use of the space environment, and in
particular the Space Shuttle, to the biotechnology and pharmaceutical industries.
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NOTE OF TRANSMITTAL
This study of approaches that might be used by NASA to market the use of
the space environment to the biotechnology and pharmaceutical industries was
performed for NASA Headquarters by ECON, Inc. Ms. Helene Najduk was the
principal Technical Officer at NASA_ Headquarters for this study and Mr. Ray L.
Gilbert was the alternate Technical Officer. ECON, Inc. is indebted to both Ms.
Najduk and Mr. Gilbert for their assist--ice ar.d guidance in this work.
The ECON Project Team for this study consisted of Mr. Ameen Ahmad, Dr.
Edwin Dupnick, Ms. Carole Gaelick and Mr. B.P. Miller. Dr. Dupnick and Mr.
Ahmad analyzed the capabilities of NASA to support research in the zero-g
environment. Ms. Gaelick reviewed and documented the past and on-going work by
NASA and others in the field of space bioprocessing, and performed the research
that led to the selection of the industrial participants in this study. Mr. Miller
developed the format for the meetings with the in dustrial participants, conducted
the meetings with the assistance of Ms. Najduk and interpreted the results.
Professor Dudley Saville of Princeton University assisted the Project Team in the
r -	 analysis of separative technologies and in a review capacity.
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A large number of industrial organizations and institutions also assisted in
making this study a success. The American Institute of Aeronautics and
j Astronautics (AIAA) provided much useful information on individuals in the
biotechnology and pharmaceutical industries who had been contacted through their
various technology transfer activities. The Industrial Biotechnology Association
i and the Pharmaceutical Manufacturers Association assisted in the identification of
the potential industrial participants. Most importantly, the study is indebted to the
nine biotechnology and pharmaceutical companies that participated in the
individual meetings. The information furnished by these companies formed the
i	 basis for the success of this study.
The interpretation of the results of the meetings with the biotechnology- and
pharmaceutical industries, the conclusions and recommendations drawn from their
meetings, and the preparation of this final report was the responsibility of Mr. B.P.
Miller.
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B.P. Miller
President
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I1. SUMMARY OF FINDINGS
.0
Since the Apollo 14 flight in 1971, NASA has engaged in research, develop-
ment and experimentation in the use of the space environment for the processing
of biological materials. Experiments involving electrophoretic and isotacho-
phoretic separation of biological materials were flown in the Apollo 14, 16, Skylab
and Apollo-Soyuz missions. After a hiatus of nearly seven years, the flight
experiments resumed under the auspices of NASA and McDonnell-Douglas
Astronautics Company (MDAC) in the Space Shuttle in 1982. Although the
experiment programs have continued with generally encouraging results for more
than a decade, the commercial potential of space biological materials processing
has not developed as rapidly as other space applications such as satellite tele-
communications, meteorology or navigation. As a result, the demand for the use of
the space environment by the biotechnology and pharmaceutical industries, and in
particular the demand by these industries for the use of the Space Shuttle, remains
uncertain.
The purpose of this study was to examine approaches that might be taken by
NASA to market the use of the space environment to the biotechnology and
pharmaceutical industries. Specific objectives included the assessment of the
needs and attitudes of U.S. biotechnology and pharmaceutical companies con-
cerning the use of the space environment, and the testing of the feasibility of a
direct marketing approach for the use of space transportation to these companies.
The study was performed by identifying potential customers for the use of
the space environment within the biotechnology and pharmaceutical industries.
Meetings were then held with selected companies to gauge the state and sources of
their knowledge concerning NASA and its programs in the space processing of
meetings.
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biological materials, NASA capabilities to support this research and the oppor-
tunities for cooperative research and development with NASA. Specially prepared
briefing materials were used to generate and focus the discussion in these
Contact was established at the senior management level with 19 biotech-
nology and pharmaceutical companies, and meetings were held with nine of these
companies. The meetings were generally informal, but were structured through the
use of a presentation style ► eport to obtain the information sought by this study.
The results of the meetings were formally documented for subsequent analysis.
r The individual meeting reports, along with the presentation material used in these
meetings are included as Appendices to this report.
of	 participation	 was obtained	 study, andThe high level	 industry	 that	 in this
C
the fact that all of the participating companies requested additional information
and/or follow-up meetings, are both indicative of what appears to be a strong
interest on the part of these companies in NASA and in the ;potential for the
processing of biological materials in the space environment. 	 However, a discon-
certing result of these meetings is the apparent lack of information (and in some
cases the presence of misinformation) concerning the NASA program. 	 This
problem is compounded by the fact that there does not seem to be an established
process for NASA to convey information to these industries. 	 For example, few of
The	 industrial	 participants	 had	 specific knowledge concerning the separative
research that is being conducted by NASA and MDAC. Even fewer were aware of
the opportunities for cooperative research and development with NASA. By design,
the participating companies in this study were chosen to exclude those biotech-
nology or pharmaceutical firms that were involved in a cooperative agreement with
NASA or were participating in other NASA studies. Only three of the companies
[
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interviewed had previously considered the use of the space environment. All three
cited a lack of information or economics as factors in their negative decisions. It
is interesting to note that none of the three took the step of discussing their
preliminary thoughts on this subject with NASA. Several of the companies 	 t
questioned the focus of the current space bioprocessing work on electrokinetic
separation, and suggested other space biological research that might be promising.
There was a widespread perception by the industrial participants that the cost of
operating in the space environment was prohibitively high, and that cost would be
an inhibiting factor in their future plans for space-based research, development or
production. The reaction of the industry participants to a direct marketing
approach was uniformly positive, and this type of marketing should be considered
as a part of any future strategy that is developed by NASA for marketing the use
R	 of the space environment for the processing of biological materials.
On the basis of this study, it is recommended that:
• NASA provide follow-up to the specific action items such as the
requests for additional information, meetings and speakers resulting
from the meetings with the companies that participated in this study.
A formal, long-term marketing plan be developed to provide for an
on-going dialogue between NASA and the biological and pharmaceutical
industries. Based upon the success in this study, direct marketing
should be an integral part of their plan.
The quality and quantity of information available to industry concerning 	 ^f -
the NASA program and the	 for cooperative research 	
t qS
s 'm roved. Databases on subjects tments,
Capabilities, ac" i ies and experimental equipment would be useful in
responding to requests for information by industry.
Actions should be taken by NASA to remove some of the uncertainty
concerning the costs of operations in the space environment. This 	 .^.
should include t	 eve opmen and pu ica ion of po i -es far the use
and p ' '	 e-Space Shuttle payload areas where policies do not ^ ^,y Se>
exist at the present time, and the development of pricing algorithms
can be used by NASA customer representatives to provide pricin
information to industry concerning these likely payload areas.
It
2. INTRODUCTION AND TECHNICAL BACKGROUND
Purification and separation of biological materials into their component parts
is of great importance in certain biomedical tields. l
 Separation of biological
materials on earth is accomplished by a variety of techniques including density
gradient centrifugation, isoelectric focusing, filtration, absorption chromato-
graphy, electrophoresis and laser activated cell sorting. Problems are associated
with each of these techniques and in some cases a number of techniques must be
applied to achieve an acceptable separation. 2,3
 In some of these procedures,
particularly electrophoresis and isoelectric focusing, gravitational effects such as
convection and sedimentation interfere with the separation process. Although
techniques have been devised to prevent or suppress these effects on earth-based
processing, these techniques are limited for cell and macromolecule separation and
can be applied to separations of only small quantities of proteins. Therefore an
increasing amount of attention has been devoted to the subject of biological
separation procedures in the low gravity environment of space where convection
and sedimentationk can be avoided. A number of experiments, commencing with an
electrophoresis experiment on Apollo 14, and continuing through the recent
co;1inuous flow electrophoresis experiments flown on the Shuttle by MDAC, have
been carried out on-orbit. These have had their successes and failures, but a great
deal has been learned and many expectations of the advantages of biological
separations in space have been upheld.
2.1 Physical Phenomena Effects
2.1.1 Gravitationally Induced
Several phenomena caused by gravitational forces on earth including sedi-
mentation, hydrostatic pressure and buoyancy-driven convection have detrimental
cc^gfi
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effects on some processing of materials. 104,5 Experimentation In a low gravity
environment eliminates these gravitationally Induced effects, and allows other
forces	 such	 as	 surface	 tension,	 volume	 charge	 or	 spacecraft	 motion	 to
predominate.
At one gravity mechanical stirring is required to keep large particles of
different molecular weight and density in suspension. This stirring may be harmful
r
L• biologicalto the separation process of chemical and	 separations and destructive to
the chemical or biological species. 5,6	 Sedimentation causes problems in ground-
based electrophoresis, which will be addressed below, and procedures to circumvent
these problems limit the rate of materials that may be processed.	 Under the low
gravity conditions of space, components remain in suspension regardless of their
densities.
Gravity creates hydrostatic pressure which causes materials to deform or
collapse under their own weight. The absence of this pressure has implications for
iR
i.
processing of certain alloys and crystals, and will eliminate the need to use a
container to confine liquids and molten metals within a container.	 The materials
be held	 by	 be	 bywill	 together	 surface tension and may 	 controlled	 use of acoustic,
electromagnetic or electrostatic fields. 4,5	 "Containerless processing" has the
advantage	 of	 eliminating	 wall	 effects	 such	 as	 contamination,	 heterogenous
nucleation, induced strain and nonuniform temperature distributions. 3,7
Buoyancy-driven convection is a particularly tricky problem in the separation
of biological materials.	 Temperature gradients result from the use of electric
fields in electrophoresic separation.	 Because on earth the warmer portions of the
fluid rises and the cooler portions settle, the separation process is disturbed by
currents resulting from this motion. 7	Techniques have been devised to minimize,
but not eliminate convective effects on earth.3
6Sedimentation and convection severely limit the concentration and purity of
the biological samples that can be separated on earth.
2.1.2 Nonitravitationally Induced
Another problem that has caused fluid flow distortion in earlier space
experiments is the electrokinetic phenomena called electroosmosis. Electro-
osmosis is not dependent upon the presence of gravity, and has occurred in both the
space and ground environments. When an external electrical field is applied to any
system contained in a closed chamber with charged walls, electroosmosis as well as
electrophoresis will occur. 8,9 Electroosmosis causes the solvent in which the
particles are suspended to flow along the surface of the chamber in one direction
and then return through the center of the chamber in the opposite direction. 8 i his
occurs because ions are absorbed by the walls of the tubes. These absorbed ions
attract a layer of oppositely charged ions in the buffer. In an electric field, the
layer of charge in the fluid moves, cagy .g the buffer flow to move along the walls.
This flow, when combined with the return flow in the center of the tube, produces
a parabolic shaped flow. This phenomenon may be avoided if the walls are lined
with an appropriate coating, 3,10 but coatings of "zero mobility" are difficult to
synthesize and even harder to maintain.
2.2 Processes
Several separation processes have been identified as good candidates for
space experimentation. Electrophoresis, isoelectric focusing, isotachophoresis and
liquid phase partitioning are techniques that might be improved under low-gravity
conditions.3
2.2.1 Electrophoresis
Electrophoresis is the transport of electrically charged particles under the
influence of a direct current electrical field. 3,11,12,13 The process is useful for
'0 n
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separating different components of a mixture, because particles will migrate at
different rates depending on their surface charge, towards an electrode with an
opposite charge. 3,12,14,15 Most biological materials when dissolved or suspended
in an aqueous solution acquire a characteristic electrical charge due to the
ionization of their functional groups, ion adsorption or other phenomena 9,16,17 and
their migration velocity per unit electric field (electrophoretic mobility of the
substance) is fixed 17 in a given buffer. Electrophoretic mobility is a complex
function of the particle's electric charge, molecular size, shape, hydration and all
the characteristics of the solvent. 14,116
The applications of electrophoresis may be broadly classified as: (1) identi-
fication and characterization of an ionized species, (2) determination of the
quantitative composition of a complex mixture (3) actual separation of the
components in a mixture. The procedure may be applied to the separations of
proteins, complex macromolecules or colloids cells etc.
2.2.1.1 Static Electrophoresis
- In static electrophoresis, materials that are to be separated are
injected into a column of stationary fluid in an electric field. The materials
migrate along the column according to their differing mobilities and separation
occurs with time. 12,18
A good separation is possible with static electrophoresis, but only a
small amount of sample car be separated at one time. Therefore it is only used for
analysis, not production. 18
2.2.1.2 Continuous Flow Electrophoresis
For separation of larger or preparative quantities of material,
continuous flow electrophoresis, which allows for continuous insertion of sample
— -	 ------- -- ---	 ---- --
and collection of fractions, may be the best method 7,17,19 A curtain of buffer
solution flows between two electrodes which establish a controlled voltage
gradient. 6,18 A stream of sample material is continuously injected into the
solution, which carries the sample from the top to bottom of a long rectangular
chamber. As the material flows through the chamber an electric field is applied
across the flow causing differently charged particles to deflect at an angle
determined by the flow rate and electrophoretic mobility of the particles, splitting
the sample into separate particle streams that exit out of separate outlets. 6.12,18
2.2.1.3 Problems
Electrophoresis is subject to significant problems, many caused by
gravity. 1,13,18 If the solute being separated is present in significantly high
concentrations it will add to the density of the supporting electrolyte, and this
density difference can result in gravity driven convection. Since concentrations of
the material must be limited, the throughput is limited. Also, some solute
particles may be sufficiently large to sediment. 13 Large biological particles of
high density settle to the bottom of electrophoresis beds and cannot be effectively
separated.
Another complication in eler!. cphoresis is that the electric field causes
heating within the medium which, as noted above, car. cause thermal convection in
ground-based processin, 14,21 producing flows that disrupt the movement of the
particles and impair the quality of the separations. In earth-based processing the
spacing between the front and rear walls of the chamber must be very small to
minimize the temperature rise caused by the current and prevent convective
perturbations from thermal gradients. This limits throughput because it allows
only a small sample stream and permits distortions from wall effects that degrade
LN
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the resolution of the device. The applied field may be limited to reduce heating
and prevent convective circulation from nonvertical temperature gradients existing
because of heat transfer to the wall. Unfortunately this restricts the degree of
(	 separation that can be obtained.3
Another problem, known as bandspreading, is caused by several factors
including differences in density between the buffer fluid and the biological stream,
elactroosmosis, differences in residence time and force that causes differential
migration of the sample. Those particles closer to the center of the stream are in
the electric field a shorter time and move shorter lateral distances. The particle
mobility is thus dependent to some extent on its location in the chamber.
Bandspreading pi-events the streams from completely separating and limits the
1 _	 purity of the output.2 ' 12 Bandspreading may be eliminated in space if a thick
enough chamber is designed.
In a low gravity environment resolution and volumetric throughput
should be vastly improved, although secondary convective effects which are
obscured in one gravity may impose finite constraints on the achievement of
theoretical maxima. 14
2.2.1.4 Electrophoresis of Cells
Isolation of functionally pure subpopulations of living cells is of central
importance to research work in immunology, cancer and other therapeutic areas. 22
Also, pure populations of cells cou. je implanted into patients with a deficiency of
that particular cell. For instance pure beta cells could be transplanted into
diabetics, and the stem cell into persons suffering from neoplasia of the bone
marrow. 5,15,22
10
The efficiency of cell culturing processes could be enhanced and
commercial production of valuable substances made possible by separating cells
into purer subfractions that have a high production rate of the substance of
interest, for culturing. 1,5,15022 Experiments have shown that production of the
enzyme urokinase is higher in certain subpopulations of kidney cells, and the more
productive cells could be separated by electrophoresis.
Unfortunately, most conventional separation techniques are inadequate
in isolating cells according to function because they are based on characteristics
such as size, density, and appearance which may be similar in cells that differ in
function. Or they are based on characteristics that are so specific that they can
only be used on previously purified cell populations. 1,5 Some powerful non-
electrophoretic techniques for cell separation now exist such as electrostatic cell
sorting, sedimentation techniques, affinity chromatography, phase partition with
polymer systems and others. But inherent problems exist with ground based
electrophoretic techniques for cell separations, including poor resolution of the
continuous flow apparatus, sedimentation and artifacts due to polymeric materials
in density stabilization. 22 However, continuous flow electrophoresis and phase
partitioning (defined below) avoid these restrictions, and may be used to separate
materials into groups that are biologically meaningful. !
 Both of these methods are
impaired by gravity-driven effects. Continuous flow electrophoresis is impaired by
sedimentation and convection as was described above and phase partitioning by
sedimentation as will be described below.
Some restrictions on cell separation may be minimized by using vertical
columns with a density gradient to stabilize the fluid against buoyancy-induced
convection, although sedimentation remains a problem with this technique. 1,19
Faggfi
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Horizontally oriented columns ro►ated slowly minimize sedimentation effects.19
Thermal convection can be reduced by applying low electric fields, but this slows
the separation.
Most of the information on cell electrophoresis has been provided by
microscope electrophoresis (static electrophoresis). This analytical technique
requires the direct observation of the migration of individual cells under a
microscope. It is a slow and tedious method and fortunately is being replaced by
techniques for rapid electrophoretic mobility determination. 11,16 Ciring the
microscopic measurement of cell mobilities thin wall capillaries are horizontally
oriented. 19 Because the applied electric field is low, and the capillaries are
immersed in a temperature controlled water bath, thermal convection is small.
Sedimentation is perpendicular to the electrophoresic migration and essentially
limits the duration of the mobility measurement.
Although column electrophoresis has only had limited success on the
ground, it is a first choice for space where the fluid could be uniform and
stationary with no disturbance due to buoyancy-induced convection or sedimenta-
tion. 1,19 Significant advances in the performance of electrophoresis could be
attained by carrying it out in space.'
General areas in cell biology that could benefit from bioprocessing in
space are:
	
•	 The study of particular enzymatic and transport processes that
are localized to specific areas of the cell by isolating from crude
cell homogenates the membrane fraction that contains the
substance of interest
t• The study of the activity of molecules that are usually hidden on
the inner surface of cell membranes by4 separating the inside out
from the outside out membrane vesicles
7
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•	 Improved selection of cells for tissue culture production of
biologicals and vaccines
•	 Cell purificaWn for direct cell therapy for treatment of immune
deficiencies.
Cell electrophoresis has profited from research using ground based
techniques and this advance in knowledge will permit space research to be better
focused. Laser techniques and computer controlled television camera based
apparatus for automated microscope electrophoresis are providing fast means to
obtain data on cell populations. Work remains to be done in establishing the
relationship between cell mobilities and various cell functions such as immunologic,
metabolic, synthetic, and physiologic activities. Another problem is that some cell
subpopulations such as T and B lymphocytes have overlapping cell mobilities and
therefore are not completely separable by electrophoresis. 23
2.2.1.5 Protein Electrophoresis
Protein electrophoresis on the other hand, is a mature technology with
a number of established ground based techniques available for analytical or micro-
preparative work. 11,16,23
Convective mixing brought on by the Joule heating is the principal
limitation of the use of electrophoresis for protein fractionation. Porous gels are
used to suppress the mixing. 8,19 In addition, the supporting gel matrix provides an
element of molecular sieving on the separation process. II Unfortunately the gel
restricts quantities that can be separated, complicates the extraction of the
fractions, and is not useful for biological cells and particles. 19
The use of these techniques appears to be satisfactory for analytical
and micropreparative electrophoresis of proteins. However, the procedures are not
applicable to large particles such as cells, and it has not yet been possible to scale
up the instruments to produce commercially significant quantities of proteins.16
X.
This is because most instruments carry out two functions: the separative function
and the Joule heat dissipation function. Heat dissipation is through the walls of the
vessels and is proportional to the square of the radius while the capacity of the
instrument, and therefore the Joule heat generated, is a function of the cube of the
radius. 23
	 Access to a low gravity facility may provide a breakthough by allowing
the use of instruments designed for the weightless environment that separate these
two f unctions. 11,23
2.2.2 Isoelectric Focusing
Unlike electrophoresis, isoelectric focusing, is not a rate process, but an
1	 13
.	 7
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equilibrium one. Isoelectric focusing utilizes a voltage gradient to set up a pH
gradient in the buffer solution. Mobility of the particle varies as a function of the
pH of the buffer. There is a value of pH, known as the isoelectric point at which
the particle 's mobility is zero. Particles migrate to their isoelectric points and
remain there becoming virtually immobilized. It is possible to achieve high
C
resolutions with this process because the boundaries of the sample band are self-
sharpening. Because the focusing process counteracts diffusion the method is
particularly useful for proteins and other macromolecule separation. Isoelectric
focusing is effected by sedimentation problems and gravity-induced convec-
tion. 1,3,15,18,24 Even slight electroosmosis can severely effect the isoelectric
focusing process because the components mobilities are approaching zero as the
proteins approach their isoelectric point. The closer the proteins are to this point
the more drastic the effect of electroosmosis. 24 A novel isoelectric focusing
machine has been developed for possible use in space by Dr. Milan Bier of the
University of Arizona.I
C,Ci^^g2
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1	 2.2.3 Isotachophoresis
Isotachophoresis differs from ordinary electrophoresis in that the sample is
inserted between two buffers. The leading buffer's anions have greater electro-
phoretic mobility than the sample, and the trailing buffer's anions have less
mobility. When voltage is applied, the different compounds tend to form sharp
distinct bands according to the mobility of the anions. Bands progress at equal
velocity through the column and over the course of migration sample ions areY	 g	 g	 P
arranged in order of decreasing mobility. The main advantage of the technique is
that any molecule that diffuses across the interface is automatically returned to
that region corresponding to its mobility. 3,15,25 If convective mixing could be
alleviated this method could produce extremely high resolution. 3
 The technique
needs a method of recovery if continuous operation is desired.
2.2.4 Phase Separation
Phase separation, or countercurrent distribution could also be improved in a
low-gravity environment where sedimentation is greatly reduced. In this tech-
nique, cells that are to be separated are mixed with two immisible liquids.
W nepending on its surface properties, the cell usually shows a preference for one
phase over the other. On earth sedimentation interferes with separation because
the droplets sediment before the partitioning reaches equilibrium. 3,18 Because
sedimentation is reduced in space a stable liquid suspension can be maintained long
enough to achieve full partitioning. An electric field must be applied across the
fluid to induce separation, since the phases do not readily separate. 18 This
technique is much less developed than electrophoresis.
t
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There was no trace of the two biological samples left in the apparatus, they
were apparently destroyed by bacteria in the system, probably during the long
I I
2.3 Space Experiments
2.3.1 Apollo 14 Experiment
On-orbit electrophoresis experimentation began in early 1971 when an
electrophoresis demonstration was performed aboard Apollo 14 on Its return trip
from the moons
The three materials selected; red and blue dye mixture, hemoglobin, and
salmon sperm DNA., 21,26 represented a broad range of molecular weights. 27 The
experiment was composed :,f three electrophoretic columns containing a borate
buffer. The goal was to observe the shape and distortions of the sample band as it
moved under the influence of the applied field. 3
 Data were acquired by
photography, and there was no attempt to collect the separated fractions. 3,21
Poor lighting and camera positioning problems impaired photographic quality,
but the separation of red and blue dyes was discernable in the photography. 3 9 27
Densitometer measurements made on the photos indicated that the boundary
between the dyes was sharper and better defined than that obtainable in a liquid
column under similar conditions on earth. Photographs taken of the space
experiment did not show lateral motion due to thermal convection or sedimentation
as is evident in similar experiments performed on earth.26
But electroosmotic flow aloe .g the column caused severe distortion of the
shape of the sample band. 3 Electroosmotic band-broadening would have been
considerably less severe had there not been a slide valve misfunction. A slide valve
that did not fully open put the dye sample in the region of maximum electro-
osmotic shear, rather than in the center of the tube where electroosmotic band
broadening would have been one third as great. 26
'k
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storage period before the demonstration took place. 21927,28 The unit itself worked
	
It 	 as designed and was later reused on other flights. 9927t2g
2.3.2 Apollo 16 Electrophoresis Experiment
A second experiment was carried out on board Apollo 16 in 1972 using an
apparatus similar in size and shape to that used on Apollo 14. Alterations were
made in the photographic setup. Photographs were automatically taken every 20
seconds during the separation run and again there was no attempt to collect
samples. The photos and astronauts' commentary were the only data.28 The
sample injection system was redesigned to provide a smoother and more reliable
release of samples. 21
One sample material, monodisperse polystyrene latex particles (PSI.) were
used in three separation columns. The first column had a mixture of particles of
0.2 and 0.8 µ m diameter, and each of the other two contained particles of the
same diameter (either 0.2 or 0.8 µ m) to provide comparative data. The material
was chosen because its electrophoretic mobility is well known, and because it is not
subject to bacterial degradation 21,27 and could serve as a model for live biological
materials.17,28
	
Ground based work using sucrose solution density gradients was used for 	
,S
comparative purposes 27,29 and an actual comparison did indicate the possible
improvements in electrophoretic separation. 27 No convection occurred during the
space experiment 21 but there were problems with electroosmotic flow and bubbles.
The sample was injected as a cylindrical disk, but by the time the particles
were visible in the photos the front of each group was already parabolic due to
electroosmosis (less than 0.5 cm from the sample input), 9,21 Electr00%raosis is the
' result of high zeta potential on the walls of electrophoretic chambers. At the time
of this experiment there was no low zeta potential coating available that would
adequately adhere to chamber walls. 28 Had this been available, electroosmosis
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could have been reduced and a distinct separation of the two sizes of latex spheres
achieved. 28 When the sample was exposed to the cell buffer and electric field,
bubbles that were motionless before electrophoresis began, starting migrating with
constant velocity towards the anode 9
The cause of the bubbles was attributed to the permeability of the silicon
tubing--expecially since it was subjected to the rapid external depressurization of
an Apollo flight. 27
A slight separation of the latex sphere mixture containing the two different
sized particles was distinguishable using very sensitive photographic tech-
niques5,9,28 spite the distortion produced by electroosmosis.3
Fluid disturbances also developed causing one of the migrating zones to take
on a corkscrew appearance. No definitive explanation is available, but it has been
suggested that the disturbances may have been caused by spacecraft motion, or
thermal or electrical gradients in the fluid. 17
Although problems with electroosmosis, bubbles and fluid disturbances did
occur, electrophoresis was accomplished and 28 the experiment proved conclusively
i the advantages of zero gravity in eliminating convection caused by density
differences. To avoid these difficulties in the future, a certain stabilization of the
fluid may be necessary. Isoelectric focusing (with protein electrophoresis) or
isotachophoresis both have built-in self-stabilization of boundaries. i7
2.3.3 cello-Soyuz Experiment MA-011
Experiment MA-011 (1975) was a static electrophoresis system that was
designed for high resolution and for testing various electrokinetic techniques such
as isoelectric focusing and isotachophoresis.7,29
The equipment developed for the Apollo experiments was extended and
combined with new sample handling procedures to work with biological
materials. 30
n it
Some of the objectives of this experiment were to:
•	 Separate and return viable lymphocyte and kidney cell fractions 21
•	 To test the effectiveness of a low-zeta potential column coating, In
eliminating electroosmosis
•	 Demonstrate the isotachophoresis of cells in space
•	 Preserve the isolation and viability of biological samples after electro-
phoresis
•	 Evaluate and analyze the resolution and sharpness of the band formed
by free zone electrophoresis in space
•	 Test the space-rated static electrophoresis apparatus. 21,25
The experiment used eight sample insertion slides, two of each of the
following:
•	 A mixture of aldehyde fixed red blood cells from human, rabbit and
horse,
•	 Human peripheral blood lymphocytes,
•	 Human fetal kidney cells,
•	 Rabbit and human red blood cells, one column fixed and one 2columnIfrozen, which were used for the isotachophoresis experiment. 	 2
The samples were frozen in liquid nitrogen until use and at the end of the run
the columns were frozen in-situ and returned to Earth in liquid nitrogen. 3,11
Overall, the equipment worked essentially as expected, although the experi-
ment could not be deemed a total success because fluid lines in some of the
columns were blocked. It would have been impossible to check these before flight
without contaminating the enclosed sterile buffer. 25
The problems of bacterial degradation of biological samples experienced on
Apollo 14 and electroosmosis experienced on Apollo 16 were eliminated. 21 Electro-
osmosis was avoided because the inner walls of the tubes were coated with a
suitable zero-surface-potential material. 25,29
}`
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2.3.3.1 Results of the Separation Experiments
Aldehyde Fixed Red Blood Cells
Fixed red blood cells were chosen to demonstrate the separation
capability of the unit because they are used as standard particles in analytical
particle electrophoresis of biological cells and extensive data on the electro-
phoretic mobility measurements of red blood cells in variopu buffers has been
published. Also, the red cells used (erythrocytes fixed in formaldehyde) are an
almost indestructible sample material resistant to mechanical stress, hemolytic
agents, and surface modifications. Another reason for this choice is that the cells
are visible to the naked eye at the concentrations used in the experiment and
therefore can be photographed. Rabbit, human and horse red blood cells were
selected because the mean mobilities of the nearest neighbor populations were
► -	 separated by about 0.4 u m s-I V-I cm so a successful separation would not be
^.	 29insignificant. 25,
I
The experiment achieved separations with sharp particle band
boundaries. Generally the data showed the observed migration agreed with the
predicted migration, overall the band pattern was a bit more compressed than
expected and the separation between horse and human cells was greater than had
been hoped for. Also the rabbit cells had greater mobility in space than was
predicted and overlapped with the human cells more than was expected. 3,25,31
Twenty flight photos taken at three minute intervals did not reveal any band
spreading or curvature due to electroosmosis.25,31
As one from cylinder (column one) was being sliced after its return to
earth the column wall fractured and the cylinder was distorted. The slices were
saved in the hopes that minimal contamination and mixing had occurred. Partial
separation of cells of the three species according to electrophoretic mobilities was
it
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evident. 25 The experiment, in the use of the other column (column five) did not
function correctly became of a blocked electrode buffer circulation port which,
probably caused a fluid flow through the electrophoresis column which opposed the
direction of particle migration and carried electrolysis products into the
column. 2S,31 This was the likely cause of the column having a pH range of 6.0 to
9.2. Separation occurred with this sample according to red cell species, but not to
the extent to show distinct bands in the photographs. 25 There were two specific
instances of sudden disruption of boundaries in the .flight photographs, that may
have been caused by random motion of the apparatus or the spacecraft. 31
In the first column, the recovery of cells was 75 percent of the
theoretical value, while in the second column it was 93 percent. 25,31 Data
collected from 100 cells in each of three sample slices from each column were
analyzed to determine whether they showed the electrophoretic mobilities that
would be expected from their locations in the column. 25,31 Estimates made of the
t:
number of each cell tyre from the electrophoretic mobility data were in general
agreement with the morphological typing estimations (for column five). in column
one however, the three sample slices all had similar electrophoretic mobilities and
did not display- the expected trends. This supported the possibility that the samples
had been mixed or contaminated when the column broke or had been mixed before
freezing.31
Human Peripheral Blood Lymphocytes
Lymphocytes serve a recognized role in immunological , nsponses to foreign
protein antigens and foreign tissue. Because of the increasing emphasis on cellular
interactions and the cellular basis of immunology, simple techniques to acquire
pure fractions of lymphocytes from heterogenoxs cell populations have been in de-
mand.2S,31 Electrophoresis was	 performed on two columns (columns two and six)
t
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containing human peripheral blood lymphocytes in the MA-011 experiments. The
following problems precluded the acquisition of adequate data.
Fluid line blockages caused gas hobbles to form around the electrodes in one
column (column two) which caused the length of time the current was established
to be cut short and therefore precluded migration of the lymphocytes. 25929
In the other column, (column six) current ran for close to 30 minutes but a
blockage of some electrode chamber fluid lines caused an acid pH throughout the
column that was 2.54 on the left, 2.28 in the center and 2.21 on the right resulting
in only a one percent viability of the returned lymphocytes. 25,31 Viability of the
returned cells in column two was six percent, and in column six was essentially
zero percent. 25
Human Fetal Kidney Cells
Human fetal kidney cells produce the enzyme urokinase which is used to
dissolve blood clots. To produce this enzyme for therape-.1tic purposes kidney cells
are grown out in cultures on mass tssue propagators from which the urokinase is
harvested. Only five percent of cells in the ki^,iey cortex produce this enzyme.
Isolation of these erokinase producing cells could substantially increase the yield of
urokinase from the cultures. That and the fact that ground-based work with
separation techniques has shown a loss of resolution due to sedimentation of the
.arge cells and :onvective mixing caused by Joule heating made this an ideal
candidate for space electrophoresis. 25,31
Results from the experiment supported the contention that these product
specific cells could be separated. Viable cells - ►ere separal d in orbit and cultured
upon return to earth. One fraction, after being grown in culture on earth achieved
a six-fold increase in urokinase beyond what w..y earth based technique has
achieved. 3,25,29,30,31
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In another band human granulocyte stimulating hormone was the chief
product of the cells, and yet another showed enhanced production of erythro-
poietin, indiLating that these products are probably produced by different type
kidney cells. 3t25
These samples were taken from only one of the two columns because the
other column developed a leak during processing.3
Isotachophoresis of Rabbit and Human Red Blood Coils ff
^	 1
f
In isotachophoresis the boundaries between species of different mobility are
sharply defined and stabilized by electrical forces. These boundaries will reform if
disturbed. Once separation has been achieved the concentration of each substance
within a compartment is uniform and remains constant throughout the run.
4 Because of this, i-'gher concentrations of components can be handled with no
deterioration of the sharp boundaries. Sample compartments are contiguous to
each other and never separate to form an intermediate zone of clean buffer. In
ruder to achieve separation a "spacer ion" of the right intermediate mobility has to
be added.
Gravity effects are more difficult to overcome than hi zone electrophoresis
I:
because of the sharpness of isotachophoretic boundaries which give rise to steep
concentration (i.e. density gradients). For this reason, protein i sotachophoresis in a
unit-g environment is alwzys conducted in gels. When planning for the ASTP
experiment began there was no ground-based apparatus in which cell isotacho-
phoresis could be carried out. A new apparatus for cell isotachophoresis was
developed after extensive ground based research only six months before the flight.
The lead time for preparation of the experiment was not lung enough for as
thorough an evaluation as would have been desired.31
j	
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Isotachophoresis was performed on one column containing a mixture of frozen
a 1
native rabbit and human erythrocytes and another column containing formalin-
fixed human and rabbit red cells.
In the experiment with the fixed red cells, the photography was not good
I	 enough to show the whole column length. Only four frames were available for
f	 evaluation. The frontal boundary moved ten mm in nine minutes, confirming the
predicted velocity, 25 although overall migration appeared to be somewhat lower
thane xpected 	 and th,_ boundary was flat and shay as expected	 y	 p	 rp  in isotacho-
phoresis with an antiosmotic coatng.21,25
In the column with the native unfixed red cells the overall migration distance
was only 60 percent of what was expected. 2S '3` Only the last four photographs of
this column showed any trace of the sample. 25
Separation between species of red ce ;s was not observed in either column
and because of insufficient migration distance the rear boundaries were not seen,
an,i it was not possible to draw conclusions concerning separation. 25 The
insufficient duration of the run (45 minutes) prevented the isotachophoretic bands
from coming into full view. 21,31
However, the experiment demonstrated the advantage of isotachophoresis in
the sharpness of the frontal boundary and concentration of the migrating zones.
The primary advantage of isotachophoresis is the potential quality of sample it may
separate. In the case of cells the future of this process depends on finding proper
spacers.31
2.3.3.2 Summary Comments--MA 011 Fxperiments
In spite of the fact that engineering and operational problems
compromised six of the eight runs attempted, the experiment showed that space
electrophoresis can provide capabilities not available on earth. 	 MA-01I
NOR
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demonstrated satisfactory sample collection, return, and preservation techniques.
Postflight analysis of the successful red blood cell separation and postflight
analysis of a separation of cortical kidney cells show the apparatus successfully
transported samples over distances of about ten cm without serious disturbances
from fluid flow, a capability possessed by no earth based apparatus. 25,30 ogress
in the development of bioprocessing was achieved by the application of near-zero
zeta potential interior wall coating on columns to prevent electroosmosis,
confirmation of biocompatibility of all appropriate hardware components and the
use of a sterile operating environment. 25231 The electrophoresis unit allowed for
two different types of separations to be conducted and allowed for multiple runs.
Not only were eight different columns processed, but the requirements for cooling,
freezing, current, fluid connections and run time were varied in orbit. 31
2.3.4 Apollo Soyuz AAA-014
This experiment sponsored by West Germany was designed to perform
continuous flow electrophoresis in space on biological cell materials with the goal
of achieving high sample throughputs at high resolution.6 The machine was
designed to work almost automatically. There was no sample collection because of
volume limitations for the instruments. Instead, the results were evaluated by
scanning the absorption pattern across the separation gap, digitizing the data and
storing both the scientific and housekeeping data on tape. 3,6,29
In addition to demonstrating continuous flow electrophoresis at zero gravity
for the separation of preparative quantities of living cells at high viability
percentage, an objective was to investigate thermal and convective properties of
chambers with high gap width.6
99a
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Samples that were separated were:
a	 Rat bone-marrow cells
a	 Rat spleen cells
a	 Mixture of human and rabbit erythrocytes
a	 Rat lymph-node cells and human erythrocytes. 29
The first three samples were freshly prepared and stored at 40C for about 45
hours preceding the experiment. The rat lymph node cells were stored at -85 0C in
liquid nitrogen. 6,29
The tape-stored data was examined several day ,. after splashdown. Proper
running of all functional blocks was confirmed but scientific data indicated that
the light source (a halogen lamp) for the absorption measuring optics had been
excessively bright and adversely affected the measuring range. The reason was the
lamp lacked internal convection because of zero gravity.3,18,29
Consequently it was difficult to interpret the recorded data. However, some
conclusions were possible because during the stationary phase irregularly occurring
pulses (called events) were recorded. The pattern of these events reflected the
expected course of the separation curves. 6,29 It was concluded that:
a	 The bone marrow sample showed an excellent separation pattern,
sharper than that measured by comparable ground equipment
a The best results were achieved with spleen cells. There was sufficient
data to identify the details of the separation and the prediction of high
separation quality in spite of high-rate sample processing was con-
firmed
a	 Well founded results from the erythrocyte separation were precluded by
lack of information
a Lymph node cells showed f9 somewhat poorer distribution due to thelack of information stored, but compared to the results of procedures
carried out og the ground the positive effect of the absence of gravity
was striking.
Ai
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2.3.5 Skylab-Experiment TV117
An attempt was made to separate human red blood cells and two proteins,
ferritin and hemoglobin using isotachophoresis on Skylab. The objective was to
determine whether low gravity could alleviate convective mixing and sedimenta-
tion problems that are associated with separations in one-gravity and achieve
protein separations to compare with gel techniques, and to determine whether
larger particles such as cells could be separated by this process.
The protein separation failed. A small amount of air had entered the system
through slight leaks that had developed. A gas bubble formed and isolated the
electrode, preventing current from flowing.
The tube  with red blood cells produced better results, although the process
was effected by electroosmosis.3
2.3.6 The Shuttle Era
Space experiments with electrokinetic separation of biological materials
began in 1971 in the Apollo 14 fiight and were cantinued at an increasing level of
:activity and sophistication through the completion of the Apollo-Soyuz mission in
1975. Because of the hiatus in the manned space flight program, flight experi-
ments using separative technology did not resume until the flight of STS-1 in 1982.
In the intervening seven years an important action occurred that could eventually
lead to a private sector rol a in the commercial development of the space
environment for the processing of biological materials. In .1976 MDAC began the
deveiopment with their own funds of a continuous flow electrophoresis device. bi
1980 MDAC signed a Joint Endeavor Agreement (JEA) with NASA to establish a
cooperative research and development program. Under this program MDAC would
conduct certain proprietary precommercial electrophoresis separation experiments
in the NASA Space Shuttle. Under the terms of the JEA, NASA agreed to provide
TVt 27
II
MDAC with transportation of the electrophoresis unit to and from orbit at no cost
to MDAC and further agreed that it would not accord similar privileges to other
private sector entities proposing to conduct experiments in continuous flow
electrophoresis. In turn, MDAC agreed to support the NASA in-house research
program in space bioprocessing by conducting separative experiments in their
continuous flow electrophoresis device with material samples provided by NASA.
In addition, NASA sponsored the development of a static electrophoresis device for
flight in the Shuttle and the development of a isoelectric focusing device for
ground testing and possible future flight.
With the flight frequency of the Shuttle increasing to nearly ten times per
year in 1984 and 1985, in comparison to manned space flight opportunities of about
once per year in the early 1970s, it is apparent that the era of the Space Shuttle
has created an opportunity for a vigorous space bioprocessing program.
2.3.6.1 Industry Participation in Space Bioprocessing--McDonnell
Douglas and Johnson & Johnson*
MDAC began investigating the prospect of space manufacturing in
-976. After several areas were considered, electrophoresis was chosen when the
company recognized that the process had never been optimized on earth because of
gravity induced limitations. Of primary interest was the fact that it appeared the
process could be scaled up in space to allow large commercial quantities of
materials to be separated, a capability that is not attainable on earth. By 1977 the
company had formulated the program, and then it approached several pharma-
ceutical companies to determine the degree of interest in the possibilities of using
space to produce new products. In 1978 a working arrangement was established
The information contained in this section was obtained from various trade
press sources, an interview with Mr. James Rose and Ms. Lynn Hansen
of MDAC on November 1983 and an interview with Dr. Glenn Kiplinger
of Johnson & Johnson on December 1983.
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with the Ortho Pharmaceutical Corporation, a subsidiary of Johnson & Johnson
(M).
Under the arrangement each company contributes in its area of
expertise. MDAC has developed the equipment, does the space processing and
ground analysis and ships the material to M. J&J has done the market research
and product selection:, will perform animal and clinical testing, decide the dosage
forms, and will package and distribute the resultant product.
MDAC intends to market their space based electrokinetic separation
s technology and services internationally, eventually working on processing multiple
products for a number of companies. The growth of this industry depends to a
large degree on decisions made requiring future on-orbit capability. MDAC has
indicated that it may be possible to process one or a limited nuather of products
using the Space Shuttle and unmanned spacecraft. But for a multifaceted
expansion the company is looking to the manned space station. According to
MDAC a permanent manned capability in space is required for them to perform
research in space, allowing for the expansion of the number of space produced
products. Without the space station the industry will be limited to a few products.
According to MDAC the present space transportation system is being
used for verification of processes and eventual production of products. &4DAC has
developed a ground-based processing system and a sophisticated mathematical
model that analyzes the effects of gravity and can determine which processes are
gravity limited and the magnitude of these limitations. From their ground work a
strong database has been built, so they know what to look for and what to test for.
On the basis of this ground based work a few samples are chosen for verification
through space processing. If manned access to the space environment were
unlimited, as would be the case if a manned space station was available, the
9^_32
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researcher could routinely run the experiments and research could be performed in
space on hundreds of products.
MDAC has given glowing reports of its space-based work to date.
Separations have been run on STS- 4, 6 and 8. These runs have established that the
process works significantly better in terms of throughput and resolution in space
than on the ground. So far, one proprietary material has been prepared and beta
cells have been successfully separated from living pancreas cells. Electrophoresis
of kidney cells done for NASA produced a new plasmagin activator, an important
enzyme that may be used to dissolve blood clots. This substance had never been
separated on thn ground because it was not possible to attain sufficient _oncen-
tration of material required. Yields up to 700 times greater and purity levels four
times higher than are achievable on the Earth have been attained by these runs.
On STS-4 the MDAC device was used to perform separations on a
laboratory standard mixture of egg albumin and rat albumin and a cell culture fluid
containing many types of protein. 3` The maximum concentration of albumen that
can be separated on the ground is 0.2 percent which is insufficient for commercial
purposes. A 23 percent concentration was achieved in the space experiment. This
yielded about 460 times more material than is possible on the ground. Comparable
success was achieved in the separation of tissue culture media. 3 ,37
The device was flown again on the next two Shuttle flights and
accomplished separation of over 700 times more materials and arhieved purity
levels more than four times greater than that possible on earth.34
In the STS-8 flight the MDAC continuous flow electrophoresis device
was used to investigate the handling of live cells before and after processing and
establishing the capabilities of the device to impruve electrophoretic separation of
live cells in space. Live pancreas cells were separated and survived the
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experiment. Because of the cells sensitivity to bacterial contamination they were
loaded into the on-boavd storage area only seven hours before lift off.35
There are indications that the test yielded separation rates at about the
levels projected but more time is required to determine whether the cells are still
able to produce hormones and enzymes as anticipated. 36
The prospect of substantially increased yield from space-based
processing appears to be a major driver behind the plans for commercial
production. A new production plant, a scaled up version of the unit flown by
MDAC in 1982 and 1983 is scheduled for first flight on the Shuttle in 1985, and is
now being developed. The apparatus will be automatic and have twenty-four times
the capacity of the current unit. It would take 16,000 columns on the ground to
achieve the quantities that will he separated by the production plant in space.
Two flights are scheduled in 1985, on STS-51-1 (i.e., flight number 27)
and STS-61-C (flight number 32). These will be the first production runs, meaning
that the returned product will undergo preclinical tests.
A modified machine will be used and payload specialists will be present
on these flights. MDAC has indicated that is is their intent to have enough test
data on products to get FDA a pproval for commercial sales by 1987.
An important observation made b; MDAC about their venture with J&J
is that it takes a combination of different groups and talents. MDAC, the initiator
of the endeavor, possesses a unique set of capabilities including expertise and
experience in the aerospace field, an active aerospace medicine department and
the foresight to see beyond the typical short term investment horizon. J&J
understands the market and has the knowledge and skills required to market the 	 j
i
product. Washington University, which has done extensive work on beta cells and is
involved in a joint research quest with MDAC which could lead to new treatments
	 i
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for diabetes, has the theoretical research capability. The beta cell separation on
STS-8 was part of this joint work. NASA provides access to the space environment 	 ^*
on the Space Shuttle. From the perspective of MDAC all nf these ingredients are
needed for a successfulro ram o experimentation  d od	 mp g	 fan product develop ent.
NASA will play a crucial role in influencing industry participation in
space processing. Industry must be assured they can depend on NASA providing a
reliable and efficient transportation system available routinely for industry use.
The lead time in developing hardware and ground based research can be long, on
the order of ten years or more. One of the concerns voiced by MDAC is the lack of 	 i
commitment or the part of government to ensure continued Shuttle availability. In
order to make a return on an investment in space processing, industry is dependent
on long-term and routine availability of the Shuttle, and before it will undertake i
investments with a long return horizon indu stry must be certain the system will be
there to support their work. A lack of commitment on the part of the government
increases the risks and uncertainities tha• a a perceived by industry in association
with a space processing project. A nationa! policy committing the Shuttle fleet to
support commercial work may have an important effect on industry decisions
k
regarding whether or not to venture into space processing. 	 ' 14^
2.3.6.2 NASA Sponsored Research
In addition to the industry program, NASA has continued the develop-
ment of an active in-house space bioprocessing program as a part of the scientific
utilization of the STS. This program has led to the development of a static
electrophoresis device which was flown on STS-3, and an isoelectric focusing
machine which is scheduled for flight in 1994 or 1985.
32
The static electroE4v-,resis experiment in STS-3, called the EEVT, had as
its goal the investigation of the electrophoretic behavior of animal cells in
suspension that is more concentrated than that possible on earth. The samples
consisted of six human embryonic kidney (HEK) cell cultures and two mixtures of
human and rabbit aldehyde-fixed red blood cells. The comparison of laboratory
results with the STS-3 resu:ts indicates that very high cell concentration is possible
in zero gravity electrophoresis, and the results are not unexpectedly different from
the electrophoresis of normal cell concentrations at unit gravity. 38
The isoelectric focusing machine under development by Dr. Milon Bier
at the University of Arizona differs in a very significant way from the MDAC and
NASA electrophoresis devices. While the goal of electrophoresis is to achieve
improved throughput, the objective of the University of Arizona isoelectric
focusing machine is increased resolution;. Laboratory tests of the University of
Arizona isoelectric focusing machine have been encouraging and it is tentatively
scheduled to fly in the Shuttle in 1984. Assuming that the MDAC continuous flow
electrohphoresis machine is capable of providing adequate resolution with
increased throughput, and that the University of Arizona isoelectric fooising
machine is capable of achieving in space adequate throughput with increasese,
resolution, in the present stage of research and development the two machines are
very likely to be complimentary rather than competitive. 39
2.4 Understanding the Potential Needs of the Biotechnology and Pharmaceutical
With the successful completion of its tenth flight during the period of
performance of this study in early 1984, the NASA Space Shuttle has demonstrated
the reliability and reproducibility of performance of an operational system. The
Shuttle will move further in the direction of full operational capability with eight
to ten flights planned for 1984, and ten to 12 flights planned for 1983. By the eno
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of 1985 all four Shuttle Orbiters will be in full use. The capability of the Shuttle to
revisit an orbiting spacecraft for retrieval, repair or replenishment of eonsumables
will be demonstrated in 1984 and again In 1985. By the latter part of this decade
the flight rate Is expected to increase to about twice per month.
In the past two decades several civilian commercial uses of the space
environment have been explored, in both the public and private sectors, and have
reached varying degrees of maturity as demonstrations, operational systems or
successful commercial ventures. These include the use of space systems for
communication, navigation and the observation of the earth and its weather. These
applications have achieved a sufficient degree of maturity so that the market for
transportation to deliver satellites to orbit to perform these services is relatively
well understood.
The use of the space environment for the processing of biological materials
was suggested in the 1960s and the first experiment involving the electrokinetic
separation of biological materials in space took place in 1971. In the early 1970s
the manned space flights that provided the opportunities for space bioprocessing
experiments occurred at roughly one year intervals in the Apollo, Skylab and
Apollo-Soyuz missions. The electrokinetic separation experiments that were
conducted in those early flights were generally encouraging but not conclusive in
terms of the improved performance of these separation techniques in the space
environment. In the main the interpretation of these early experiments was
hampered by test eq. ;ipment, instrumentation and procedural problems. Each
successive experiment appears to have overcome most (if not all) of the problems
encountered in the preceeding flights. However, progress was sl -^wed by the
infrequent flight schedule. In the period following the last of the early flights, the
A} ollo-Soyuz mission in 1973, both NASA and MDAC invested resources in
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Improving the reliability and performance of, the electrokinetic separation equip-
ment that would later fly in the Shuttle, ,nd in Improving the theoretical
understanding of the behavior of electronkinetic separation processes In the zero-G
environment. As a result of this investment, and as a result of the fact that the
increased flight frequency of the Shuttle provides the opportunity to more rapidly
correct problems as they are encountered in filght experiments, the performance
of the equipment used in the Shuttle bioprucessing experiments has improved, and
both the quality and quantity of results increased. Although inuch progress has
been made since the first space-based electrophoresis experiment in the Apollo 14
flight in 1971, the use of the space environment for the processing of biological and
pharmaceutical materials has not matured as rapidly as other applications. As a
result, there is a great deal of uncertainty concerning the potential requirements
of the biological and pharmaceutical industries for the use of the space environ-
ment. This uncertainty has made it difficult for NASA to plan for the space
transportation needs of these industries and to develop a marketing strategy for
the space bioprocessing area. The purposes of the study are to obtain a better
understanding of the needs of the biotechnology and pharmaceutical industries for
the use of the space environment, and to identify steps that might be taken by
NASA to make the use of the space environment more attractive to these
industries.
35
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3. THE CAPABILITIES OF NASA TO SUPPORT THE PROCESSING OF
BIOLOGICAL AND PHARMACEUTICAL MATERIALS
A wide variety of separation technologies have been developed and are used
by the biotechnology and pharmaceutical industries. The ability to separate a
biological substance of particular interest from impurities and/or other substances
is an important step in the research, development and production of a new
biological product. For example, during the research phase it is necessary to
obtain small quantities of the biological substance of interest for analytical
purposes. Quantities in the range of micrograms to milligrams are needed in the
research phase. At this early stage cost is not a major factor and various
separative techniques are often used in the laboratory to obtain the small
quantities needed for analytical purposes. Further development of the substance,
including testing and evaluation, requires quantities in the range of tens to
hundreds of liters. During the development phase cost becomes increasingly
important along with issues of the feasibility of production. Economic factors
continue to be of major importance when the substance moves into the production
phase. While electrokinetic separation techniques may be used to produce
analytical quantities, in a unit-g environment electrokinetic separation techniques
are not generally considered to be an economically feasible way of manufacturing
the quantities needed for either research or production because of the limitations
on throughput resulting from the effects of gravity.
While the emphasis of the space bioprocessing program to date has been on
the research, development and demonstration of electrokinetic separative tech-
niques in the zero-g environment, continued research may lead to other possible
applications. For example, the characterization of the structure of proteins is
important to the biotechnology industry. At the present time the characterization
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of crystals and x-ray crystalography is limited by the fact that only a small number
of proteins can be grown into crystals that are large enough for this purpose.
Research with chemica! substances has shown that larger crystals can be grown in
zero-g than in a unit-g environment. A protein crystal growth experiment flown in
the Shuttle/Spacelab 1 in November 1983 could lead to further research and
development in the field of protein crystal growth in the space environment. 40,41
3.1 What Does the Space Environment Offer?
Three environmental attributes: namely, gravity, atmospheric pressure and
radiation are significantly different in space than on the surface of the earth. The
differences in these attributes are the factors that cause physical processes such as
electrokinetic separation or protein crystal growth to yield different results in
space than on the surface of the earth. Table 3.1 summarizes the effects of these
attributes on electrokinetic separation processes. The attribute of principal
interest is the microgravity environment of space, and the resul:::nt absence of
gravity-induced effects in electrokinetic separation processes. While benefits to
other processes from the hard vacuum and radiation environments of space may be
TABLE 3.1 ATTRIBUTES OF THE SPACE ENVIRONMENT AND
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found through further research, the result of more then ten years of experimenta-
tion have clearly shown the benefit of the microgravity environment in terms of
improved throughtput and the potential for improved resolution in electrophoretic,
isotachophoretic and isoelectric separative processes.
3.2 NASA Capabilities for Microgravity Research and Development
NAS A has a number of facilities and systems that are capable of simulating
or providing access to the near zero-g environment of space. These can be broadly
categorized into ground- and space-based facilities, where the ground-based facili-
ties can simulate or provide access to the near zero-g environment for durations in
the range of seconds to minutes, while the space-based facilities can provide
exposure durations in the range of days to months.
t.	 3.2.1 Ground-Based Facilities
Table 3.2 summarizes the NASA ground-based (non-orbital) facilities. These
consist of a drop tower, drop tubes, aircraft and sounding rockets.
The drop tower and drop tubes are located at the Marshall Space FLght
Center, Huntsville, AL. The drop tower and drop tubes can achieve low gravity for
1 -
qa
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TABLE 3.2	 NASA GROUND-BASED FACILITIES
FACILITY LOCATION DURATION OF EXPOSURE
TO HEAR ZERO-f,
DROP TOWERS MARSHALL SPACE FLIGHT CENTER, AL 2 - 5 SEC.
LEWIS RESEARCH CENTER	 ON
DROP TUBES MARSHALL SPACE FLIGHT CENTER, AL 5 SEC.
AIRCRAFT
• KC-135 JOHNSON SPACE CENTER, TX. 20 - 25 SEC.
• F-lot DRYDEN RESEARCH CENTER, CA 60 SEC.
(REPEATED SEVERAL
TIMES PER FLIGHT)
SOUIDING ROCKETS UNITE SANDS, 0 5 MIN.
s
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about two to fire seconds in free fall. One of the drop tubes can use a melting
apparatus in a bell jar. The bell jar and tube can be evacuated to low pressure or
can be back-filled with helium. The melting apparatus can achieve temperatures in
the range of 600 C to 3500 C and can accommodate samples in the size range of
lmm to 5mm. Both a 30m and 100m drop tube are ava;lalbe. The drop tower is
100m high and can attain a free fall duration of about five seconds. The drop
tower can accommodate an experiment payload of about 2' x 2.5' x 41.
The sounding rockets are launched from the U.S. Army missile test range in
White Sands, NM. NASA plans to call for launches twice per year; however,
because of funding limitations there was only one launch (SPAR 9) in 1982, and one
(SPAR 10) in 1983. The trajectory of the rocket creates a near zero-g condition in
the vicinity of apogee for about five minutes. The rockets are capable of carrying
a payload of about 1000 pounds in a payload compartment that is 16 inches in
diameter and four feet high.
NASA also uses two aircraft to simulate the zero-g attribute of the space
environment. The aircraft simulate the near zero-g attribute of the space
environment by flying a parabolic trajectory. While each trajectory is brief, the
maneuver can be repeated several times per flight. One is a KC-135 (a military 	 ro
version of the Boeing 707) based at Johnson Space Center in Houston, TX. The KC-
135 can achieve near zero-g for about 25 seconds and is capable of flying this
maneuver up to 50 times per flight. As it is basically a cargo aircraft, it can
accommodate large payloads in a cargo bay that is 6' x 10' x 7 1 . The equipment can
be attended by operators. The second is a modified military fighter aircraft, an F-
104, based at Dryden Research Center s CA. Because of its capability to reach
higher altitude, the F-104 can fly a parabolic trajectory for about 60 seconds. The
maximum weight of experiments that can be used in the F-104 is 70 pounds.
E(K^gfi 1
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'	 Because electrokinetic separation processes require process times that are
i
longer than the maximum duration of near zero-g exposure that can be achieved in
the NASA ground-based facilities, the ground-based facilities have not been used
for bioprocessing research involving electrokinetic separation.
I
	j	 3.2.2 Space-Based Facilities
Although the space bioprocessing experiments that have flown to date are not
either unusually large or heavy, they have not been automated and all have
required some degree of human intervention. As a result, all of the bioprocessing
experiments have flown in manned spacecraft. For this reason, the Space Shuttle
is the space-based capability that will be used for the next several years to support
space bioprocessing research and development. With its high flight frequency of
about once per month in 1984, building to about twice per month in a few years,
and its ability to carry mission specialists to attend to the experimental equipment,
the Shuttle has and will continue to be used for space bioprocessing work both by
NASA and the private sector.
As shown in Table 3.3, the Shuttle provides a wide range of accommodations
for materials processing experiments in the space environment. These range from
small self-contained experiments that o perate in an automated manner, and
interface with the Shuttle only for power and operating mode commands, to large,
complex experiments that are installed in the Shuttle payload bay and are operated
by a member of the Shuttle flight crew working for the organization conducting the
experiment. For example, the MDAC continuous flow electrophoresis device has
been accommodated in a mid-deck locker in the crew compartment area, while the
protein crystal growth experiment was performed in the Spacelab. The Spacelab is
a habitable, pressurized module that is 9' long by 13' in diameter. The Spacelab
system is modular and can be configured as one or two habitable modules in
40
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combination with pallets that are neither habitable nor pressurized. Spacelab can
accommodate up to about 6000 pounds of evenly loaded equipment. The experi-
ments are rack mounted, and those installed in the modules can be accessed during
flight. The experiments can be self-contained, or can be controlled from the
Spacelab module, the Shuttle aft deck, or the ground.
With its present capability the Shuttle can provide up to ten days of exposure
to the ne- - zero-g environment. This limitation on on-orbit duration is probably
the only performance constraint on the use of the Shuttle for space bioprocessing.
Although proposals have been made to extend the on-orbit duration capability of
the Shuttle, at the present time the only way to obtain a longer exposure to near
zero-g environment is to use the Shuttle to place an automated spacecraft into
orbit. With its revisit capability the Shuttle could support space bioprocessing
i .
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work by revisiting the automated spacecraft for maintenance and to replenish its
supply of expendables and raw materials, and to return the processed product to
earth. The Shuttle launched automated spacecraft could then remain :n orbit and
be revisited at several month intervals by the Shuttle.
Example schedules for the use of the Shuttle are shown in Figure 3.1. These
schedules are compatible with the times needed for the development of flight
experiment equipment and the planning for flight experiments. For example, small
self-contained payloads require a lead time of about IS months and should be at the
launch site about two to six months before the scheduled launch for integration
with the Shuttle. Larger payloads such as those installed in the payload bay need
longer lead times for development and integration. Equipment with complex
interface and design requirements may require a lead time of up to three years.
Once installed in the Shuttle, access to the experiment or payload can be attained
up to a few hours before launch. These schedules are typical, and NASA has shown
that it can be flexible to accommodate the schedule needs of precommercial and
commercial payloads.
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FIGURE 3.1 EXAMPLE TIMELINES FOR ORBITAL FACILITIES
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In 3anuary 1984, President Reagan proposed that NASA begin the develop-
ment of a spare station that would provide the capability for a permanent manned
presence in space. Space bioprocessing is otie of the commercial applications that
has been suggested for the space station. Because of the lead times for
development and production, it is not likely that the first U.S. space station will be
operational before the early 1990's. For this reason, the Shuttle, and its capability
to deliver, retrieve and revisit payloads will remain as the principal space-based
capability to support bioprocessing for the next eight to ten years.
3.3 NASA /Industry Working Relationships
Under the Space Act of 1958 that created NASA, the agency is mandated by
Congress to conduct its activities in a manner that contributes to the preservation
of the role of the U.S, as a leader in aeronautical and space science and technology
and their applications. As the technology and systems developed by NASA began to
mature the agency recognized that certain of these had commercial potential, and
it began an on-going effort to find the mechanism to involve the private sector in
the commercialization of these technologies and systems. In the case of space
bioprocessing, this involved a clear recognition on the part of NASA that it was
responsible for the development of the technology base that could lead to private
sector ventures, but that it had no direct involvement in the processing of
materials for commercial markets. The development of specific commercial
products and/or services from the NASA technology base and capabilities was and
continues to be regarded as the sole domain of the private sector.
In the late 1970s, NASA put in place institutional and contractual arrange-
ments to foster the participation of the private sector in space bioprocessing and
other areas of space materials processing. 42 The institutional arrangement took
the form of establishing a Commercial Applications Office in the Materials
m	 mom
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Processing In Space Projects Office in the Marshall Space Flight Center. This
office was assigned there esponsibility of assisting r	 	 	  p ospective commercial interests
by providing information on NASA sponsored work, and by providing access to the
work and to NASA capabilities. The office was also charged with the job of
t clarifying the policies of NASA with regards to commercial rights in intellectual
property, liabilities, equipment leasing and pricing. In August, 1979, Dr. Robert A.
Frosch, then the administrator of NASA, took a major step to involve NASA in a
i	 more direct way in the process of commercialization when he issued NASA Notice
f '	 79-70, Guidelines Regarding Joint Endeavors with U.S. Domestic Concerns in
t
Materials Processing in Space. These guidelines recognized that the normal market
forces had not brought about the participation of the private sector, and that it
was necessary for NASA to encourage the entry of the private sector into space
materials processing through the sharing of cost and risk. The guidelines defined a
new concept for the public sector called a Joint Endeavor. Under the Joint
Endeavor concept the private sector could propose to enter into a formal
agreement with NASA for precommercial research and development in space
materials processing for work that was both consistent with NASA program
objectives, and which involved a significant level of technical uncertainty and risk.
If the proposed private sector activity met NASA's criteria, NASA could provide
flight time on the Shuttle, technical support and the use of other facilities at no
cost to the commercial participants. A fundamental ground rule of the Joint
iEndeavor concept is that each party funds its own participation. In January 1980
' MDAC entered into a Joint Endeavor Agreement with NASA for research,
development, flight experimentation and precommercial demonstration of the
practicality of the use of continuous flow electrophoresis technology for space
materials processing. 43 Under the terms of this agreement, NASA will provide
I	 .
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MDAC with a number of flights of the MDAC continuous flow electrophoresis
equipment in the Shuttle at no cost to MDAC. Further, NASA agreed not to enter
into other Joint Endeavor Agreements to provide access to the Shuttle at no cost
to other commercial or international entities engaged in the development and
demonstration of electrophoretic separation technology for the six years of the
agreement. In return, MDAC agreed to provide the continuous flow electrophoresis
apparatus, test samples and to actively pursue the commercial potential of this
separative technology and the resultant products. 	 At a later date the Ortho
Division of 3&J became associated with MDAC in the exploration of the commer-
cial products that might be obtained in this space bioprocessing venture.
Since 1980, the concept of the Joint Endeavor Agreement has been expanded
to provide for other forms of working relationships between industry and NASA.
Figure
	
3 .2 illustrates this range of possible working relationships.
	 With the
addition of Guest Investigator and Technical Exchange Agreements, NASA now has
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a continuum of possible flexible and cooperative working relationships with the
industry. In Figure 3.2 the left and right hand zones depict the more conventional
• forms of working relationships between government and industry, while the center
zone illustrates the cooperative, risk sharing relationships. In the Company Funded
mode (left), all costs are borne by industry, with NASA retaining responsibility for
interface control, safety and scheduling. The objectives are selected by industry
1 and all data rights are retained by industry. In the Government Funded Contract
mode, NASA can contract with industry (or a university) to perform the work and
all costs are borne by the government. Variations of the Government Funded
Contract mode include degrees of cost sharing, but in general, the objectives are
selected by the government and data rights are the property of the government.
The cooperative modes imply a degree of mutual interest between industry and
NASA, with a progression of involvement and commitment from an agreement to
exchange data, to the possibility of industry appointing a scientist to collaborate
with a NASA sponsored investigator to a Joint Endeavor Agreement to shwa cost
and risk. In each of these three cooperative modes the government does not fund
any of the work done by industry, nor (under the terms of the agreement) does
industry compensate NASA for data or services. Each party funds its own
activities separately, working together toward the common objective of commer-
cializing the NASA developed space materials processing technology. With this
continuum of working relationships NASA and industry can design a relationship to
fit the mutual needs of both parties. Through these cooperative agreements
industry and government can achieve mutually supportive roles in space L.--process-
ing experimentation and development.
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4. PERCEPTIONS OF U.S. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
CONCERNING THE USE OF THE SPACE ENVIRONMENT
At the oudset it was decided to focus this study on a particular application of
NASA capabilities; namely, space material processing. Within this broad context,
it was then decided to examine the potential uses of the space environment oy the
biotechnology and pharmaceutical industries. These choices were based upon the
fact that NASA has been involved in research, development and experimentation
with biological materials in the space environment for nearly 15 years, and the
desire to focus this work upon a specific industrial application.
An important objective of this study was to assess the needs and attitudes of
U.S. biotechnology and pharmaceutical companies concerning the potential use of
the space environment. The insights gained from an improved understanding of the
needs and attitudes of these industries could then be used to identify actions that
might be taken by NASA to facilitate the development of future commercial space
bioprocessing ventures. Today, the Space Shuttle is the predominant image of the
space program. Moreover, the Space Shuttle represents the likely NASA capability
that will be used during the next decade to transport to orbit, revisit or retrieve
space bioprocessing equipment. With the present capability of the Shuttle the
space bioprocessing equipment can be attached to the Shuttle, remain in the near
zero-g environment for up to ten days and then returned to earth, or the Shuttle
can be used to deliver automated space bioprocessing spacecraft to orbit. These
automated space bioprocessing laboratories could be revisited by the Shuttle at
monthly or longer intervals to replenish consumable materials and bring back the
finished product. Because of the predominance of this existing capabili ty, the
study of necessity focussed on the potential needs and perceptions of the industries
relative to the Space Shuttle and systems that could be supported by the Shuttle.
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In this manner, the primary objective dealt with issue of the potential use of the
space environment by the biotectuiology and pharmaceutical industries, and specifi-
cally with the potential of NAaA as an agency, and the Space Shuttle as
transportati: in system to support a broadening of commercial interests in space
bioprocessing.
A second objective was to test the feasibility of a direct approach to the
marketing of space transportation. In this context, the direct approach involves
the identification and contact of potential "customers" by "sales" person:-nel in an
effort to "sell" the use of the Space Shuttle. This view of a direct approach to
marketing can be contrasted to an indirect approach which relies upon advertising
(both paid and free) to stimulate potential customers to seek out NASA. Direct
marketing is proactive while indirect marketing is largely reactive. Thus, the
second objective dealt with the question of tools to support a direct marketing
approach, and the success of this type of approach in eliciting interest on the part
of potential customers.
4.1 Approach
To satisfy the objectives discussed above, an approach was developed that
involved the use of a direct marketing approach to assess the perceptions of U.S.
biotechnology and pharmaceutical companies concerning the use of the space
environment for research and development that could lead to commercial space
environment for the research and development that could lead to commercial space
bioprocessing ventures. Fsgure 4.1 is an overview of the approach.
Based upon the objectives, the product to br examined in the market
assessment was identified as the use of the space environment, and specifically the
use of the Space Shuttle to provide the access to the space environment. The
potential customers for the use of the space environment were identified as U.S.
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FIGURE 4.1 OVERVIEW OF APPROACH USED IN ASSESSMENT
companies involved in biotechnology and/or pharmaceutical research, development
or product manufacturing. As shown in Figure 4.2, criteria were developed for the
selection of the companies to be contacted. Using standard industry and business
studies a candidate list of nearly 100 biotechnology and pharmaceutical companies
was prepared. The list was reviewed with representatives of the Industrial
Biotechnology Association (IBA) and the Pharmaceutical Manufacturers Association
(PMA) to identify those companies that were considered by their peers to be more
innovative and forward looking in their research programs. The objectives of the
study were reviewed with the IBA and PMA and the cooperation of these two trade
associations were solicited. The trade associations assisted by identifying specific
individuals in their member companies that they believed would be the most
productive point of initial contact. The value of this assistance cannot be
overstated, particularly in dealing with the large pharmaceutical companies that
have large headquarters staffs and multiple divisions. Through the assistance of
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FIGURE 4.2 SELECTION CRITERIA FOR COMPANIES TO BE CONTACTED
these industry associations the study team was able to identify the individual who
was most likely to be vu *-erested or receptive to the proposal for a meeting to
discuss the potential use of the space environment.
Those companies in which the ECON study team had contacts as a result of
previou- work with this industry were also identified. In order to remove potential
bias from the set )f companies to be contacted relative to the feasibility of the
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direct marketing approach, those companies presently involved with NASA either
through a Joint Endeavor Agreement (JEA) or through the space station studies
were removed from the list. The remaining list was further narrowed on the basis
of product mix, and :hose companies located in Canada and Europe were removed
from the list. The remaining list contained 19 companies, and was roughly evenly
divided between large, traditional pharmaceutical companies and newer biotech-
nology companies.
The 19 companies that were contacted are listed in Table 4.1 along with the
result of the contact process. The contact process was started by a letter to a
senior person, usually a Vice-President in the case of the large pharmaceutical
companies, or the President in the case of the biotechnology companies. The
ability to make an initial contact at a high level was believed to be important at
the outset of the study, as experience of the study team in similar research
projects had shown that there is a greater likelihood of the data collection process
succeeding if it has the attention of top management. Appendix A is a copy of this
letter. Telephone calls were then made to set up the meeting. As shown in Table
4.1, ten of the 19 contacts resulted in either a statement that the company was not
interested in participating in the meeting, or in no response. The no response and
not interested category is almost evenly divided between large pharmaceutical
companies and smaller biotechnology c ,)rr -anies so that it is difficult to draw any
conclusion concerning the relationship i.etweer, interest and size of company. Of
the nine companies with which meetings were held, four were biotechnology
companies, four were large pharmaceutical co -,)anies and one was a start-up
venture in separative technology in the biotechnology field.
In parallel with the contact process, the material to be used in the meetings
with the companies was prepared. The material consisted of a presentation style
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report tilted "The Potential Use of the Space Environment for the Processing of
Biological Materials." The presentation was designed to be covered in about one
hour and was intended to facilitate discussion. It introduced the topic, reviewed
past and current flight experiments, and provided an overview of NASA capabilities
to support bioprocessing research in a microgravity environment. The presentation
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report is contained in Appendix B. Following the first meeting a few deficiencies
in the presentation report became apparent. The report was modified and the style
of the meeting was changed slightly from a formal presentation to an informal
discussion with the report as the focus.
4 7 k+r1V-t11ra of tha Unntinac
The meetings with the participating companies were intended to follow the
format of informal discussions to the maximum extent possible, rather than the
format of a presentation or a structured interview. In the meetings an effort was
made to begin a dialogue with the representatives of the participating company,
and to place the emphasis of the discussion on those aspects of the past or present
space bioprocessing experiments, on those aspects of NASA's capabilities, or on
those aspects of the possible cooperative working arrangements between NASA and
industry that were of most interest to the company. However, the meetings did
have specific information gathering objectives as well as information transfer
objectives. As discussed in Section 4.1, the information transfer objectives were
achieved through the discussion of the material contained in Appendix B. Figure
4.3 illustrates the general flow and structure of the meetings. The decision
structure shown was adhered to to the maximum extent possible without disrupting
the focus of the industry participants on specific aspects of the NASA program
that might be of interest to there. In some cases, at the conclusion of the meeting
it was possible to address questions that had not been previously answered in a
summary of the discussion. However, as will be discussed below, all of the
questions were not covered in all of the meetings.
4.3 Responses
Since meetings were held with only nine companies it is not meaningful to
view the results as a database that is amenable to statistical analysis. With this
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number of participants it is more appropriate to look for general trends and
positions articulated in discussion that might be indicative of the perceptions of
these industries concerning the .
 NASA program and the opportunities for
commercial development. Several general observations of this nature can be made
from the meetings, and they are discussed in the following sections. The detailed
reports of the meetings with the individual companies are contained in Appendix C.
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4.3.1 Interest in Space Bioprocessing
Nineteen companies were contacted by letter and telephone with the specific
objective of setting up a meeting. only five companies responded negatively with
a statement that they were not interested in participating in the study. Nine
companies expressed an interest in participating and meetings were held with these
a
nine companies. In five additional cases it was not possible to reach the individual
to whom the letter had been addressed or to get that person to designate an
alternate contact. It should be noted that only about one month elapsed between
the start of the contact by letter and the meetings with the participating
companies. With additional time and persistence it is likely that it would have
f	
been possible to arrange interviews with some of the five companies where contact
s•	 could not be made irl the time available for this study.
The interest of these industries in space bioprocessing was also evident in the
meetings. All of the companies that participated asked for additional information
and/or follow up meetings. In general, the requests were aimed at obtaining
information about a specific area of experimentation, to obtain information that
would be useful ;o the company in their consideration of the use of the space
9
I'	 environment, or to more widely disseminate the information discussed in our
meeting.
4.3.2 Availability of Information
Although space bioprocessing is not a new field, and the potential benefits
have been widely publicized, a disconcerting result of the meetings was the lack of
prior knowledge of the NASA program on the part of the industry participants.
Most of the participants were generally aware of the fact that NASA was involved
in space bioprocessing research and development, and that MDAC had flown
experiments on the Shuttle. Few had specific knowledge of the separative
SS
experiments conducted by NASA or MDAC. Similarly, few of the participants were
aware of the opportunities for cooperative pre-commercial research and develop-
ment programs (such as the 3EA) with NASA. The most common answer to
questions aimed at probing how the participants maintained their knowledge of the
space bioprocessing program was through the local TV and newspapers. One of the
participants said that his company reviewed the NASA testimony to Congress, or
had given testimony in support of the NASA space materials processing program
and two said that they used personal contacts within NASA to obtain information.
4.3.3 Have the Companies Considered the Use of the Spare Environment?
Of the nine companies that participated in this study, three had previously
considered tlr: possible use of the space environment. In each case the consider-
ation was informal and did not reach the status of a formal proposal within the
company before it was discarded. In the case of a start-up biotechnology company
the proposal was set aside because of a lack of resources, while two large
pharmaceutical companies indicated that economics was a major factor in their
negative decision. None of the companies apparently took the step of discussing
their preliminary concept or proposal with NASA. A lack of information was the
most usual reason given for not considering the possibility of conducting space
based biotechnology or pharmaceutical research.
4.3.4 Flectrokinetic Separation as the Focus of Research in Space
Bioprocessing
Several of the companies that participated in the study qu°stioned the
reasons for the focus of the NASA and MDAC space bioprocessing work on
electrokinetic separative techniques. In particular, two of the biotechnology
companies and one of the pharmaceutical companies essentially characterized the
continuous flow electrophoresis work in space as a 113olution looking for a problem."
The fact that electrokinetic separation techniques are hampered by sedimentation
1; 7 _U
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and convection effects in a unit-g environment was not questioned, and it was
agreed that the absence of gravity in space could improve the performance of
these separative processes. However, it was pointed out that the problems
resulting from the effects of the unit-g environment on electrokinetic separation
were recognized more than a decade ago. As a result, techniques such as gel
electrophoresis have been developed to reduce the effects of gravity in electro-
kinetic separation proceesses, and that other separative processes such as affinity
chromotography that are not affected by gravity have since been developed.
Several of the participants suggested that research in the field of protein
crystal growth in the space environment might be a productive area to investigate.
Others suggested the investigation of effects of the absence of gravity on cell
efficiency (productivity and fusion frequency), magne-^ic separation and the
behavior of immobilized enzymes.
4.3.5 The Economics of Operating in Space
There was a widespread perception amongst the participants that the cost of
operating in space was prohibitively high, and that economics would probably
preclude the use of the space environment for the manufacturing of production
quantities of biological or pharmaceutical materials. Production quantities were
generally identified to be in the range of hundreds to thousands of kilograms. The
perceived economic barrier to production in turn becomes a barrier to the
consideration of the space environment for product development (i.e., the manu-
facture of preparative quantities), as cost and the considerations of scale-up to
production become im portant in the development phase. For example, one of the
participating companies said that they had just built a production facility that
would hopefully have a life of about forty years at a cost of about one Shuttle
flight (about $70 million). In other cases a concern was eXrressed that the
"fi
Y
I57
company lacked the technical capability to develop the test equipment to work in
the space environment, and that the company would have to bear the entire cost of
developing the space test facility. As indicated in Section 4.3.2, most of the
companies were unaware of the opportunities for a cooperative research and
development program with NASA, and were certainly not aware of the possibility
fog cost-sharing through cooperative programs. This is a clear challenge to NASA
to show the cost effectiveness of space processing for both research and develop-
ment, and production.
4.3.6 Participant Reaction to a Direct Marketing Approach
A major concern at the outset of this study was the question of how the
participants would react to a direct marketing approach. The concerns ranged
from the accessibility of the key industry personnel contacted for the proposed
meetings, to the possibility of negative reactions on the part of the participants to
the use of the presentation style report as a means of transferring information
about the NASA program to the participants and focussing the resultant discussion.
It is clear from the results of this study that there is sufficient interest in the
biotechnology and pharmaceutical companies in the space program, the Space
Shuttle and space bioprecessing to motivate key industry personnel to make
themselves available for the type of meeting conducted in this study at their
facility. Furthermore, in eight out of the nine meetings the presentation style
report worked well as a means of conveying information and eliciting and focusing
discussion. In the ninth case the principa! industry representative was available for
only one hour, and it was not possible to cover the presentation material and allow
for a discussion in the alloted time. As a result, only parts of the presentation
material were covered in this meeting.
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4.4 Interpretation of Responses
4.4.1 The Need for a Continuing Dialogue and for Additional Information
All of the companies contacted in this study indicated a desire to continue to
interact with NASA on the subject of the opportunities for commercial partici-
pation in the space bioprocessing program. This request took several forms.
Several of the companies asked if it would be possible to arrange follow-up
meetings with NASA personnel involved in scientific aspects of the NASA program.
One major pharmaceutical company specifically asked if it would be possible to
provide an individual with a broad scientific background in space bioprocessing to
talk to their senior scientific people. The same pharmaceutical company expressed
an interest in having a NASA person discuss the engineering aspects of space
bioprocessing with a large group of their middle management people. One of the
biotechnology companies stated that they would be interested in convening a
special meeting of their scientific board, consisting or top level research scientists
from Harvard and MIT for a further discussion of the scientific aspects of the
program.
The same companies asked for additional information in several forms. The
most common request was for databases that their staff could examine at their
convenience or when a particular requirement arose in the conduct of their own
work. For example, almost all of the participants asked if NASA could provide
information such as titles, abstracts and Principal Investigator identification on the
space bioprocessing program. They asked for information on the nearly 400
completed or planned Get-Away-Special experiments and on the equipment and
facilities for space experimentation that are available from NASA. It is clear from
the comments of the industrial participants that databases of the sort described
could be a very useful tool in future interaction with the biotechnology and
pharmaceutical industries.
III
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4.4.2 The Need to Demonstrate the Potential Usefulness of the Space
Environment to Multiple Aspects of Space Bioprocess ng Research
Several of the participants, particularly biotechnology companies, questioned
the emphasis of the NASA program on separative research. Comments such as
"outdated technology," "solution looking for a problem" were made by several
participants. One participant went so far as to state that while the pharmaceutical
industry viewed space bioprocessing (i.e., space-based electrokinetic separation
research) as a means to an end (the end being a new chemical or biological entity),
it appeared as if current programs were perceived by their sponsors as an end unto
themselves. In this connection, several of the participants suggested that other
areas of research such as the effect of zero-g on cell productivity and on protein
crystal growth were also potentially important. Given these suggestions by the
participants in the study, it would appear to be worthwhile for NASA to consider
other avenues of research in order to avoid the equation of space bioprocessing
with space-based research in separative techniques.
4.4.3 Economic Feasibility
Almost every discussion with the industry particpants in this study eventually
got to the issue of cost and economic feasibility. Although the participants were
receptive to concepts of low cost experiments such as the Get-Away-Special, or
risk sharing for pre-commercial work through mechanisms such as the JEA, the
participants were uneasy about the possible costs of processes that might require
repetitive flights or production processes that might require space-based manufac-
turing facilities. One possibl y interpretation of this response is that industry does
not have sufficient data or experience with which to formulate its own estimates
of the economic feasibility of space-based research, development or production.
While it would clearly not be desirable for NASA to put a price tag on an industry
program that does not yet exist, it would be desirable for NASA to be in a position
t
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to remove some of the uncertainty in the mind of the industry concerning cost.
Whether this is best done by creating a few standard examples that might bracket
the range of possible interest, or by creating a parametric cost/price model that
might be used interactively and iteratively by NASA with industry personnel needs
further consideration.
4.4.4 Direct Marketing Approach
The industry participants were receptive to the direct marketing approach
used in this study. The 19 initial industry contacts made in this study resulted in
nine highly productive meetings. With additional time and resources it is likely
that the number of meetings could have been increased. The presentation style
material that was prepared for these meetings, as shown in Appendix B, worked
well to focus and generate discussion. Based on the reactions of the industry
participants, it is believed that this type of material could be an important adjunct
to future efforts by NASA to develop the use of the space environment by
biotechnology and ph.-Armaceutical companies.
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S. ACTIONS THAT COULn BE TAKEN BY NASA TO
FACILITATE THE MARKETING OF THE SPACE SHUTTLE
To THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
The results of the study support several general conclusions concerning the
perceptions of the industries that participated in this study relative to the
potential use of the space environment for the processing of biological materials.
The conclusions in turn can lead to recommendations for action that could be taken
by NASA to facilitate the marketing of access to the space environment to these
industries. These conclusions and recommendations are discussed in the following
sections.
5.1 Improve the Quality and Quantity of Information Available to Industry
As discussed in Sections 4.3.1, 4.3.2 and 4.4.1, few of the industrial partici-
pants in this study had an) , specific information concerning the NASA space
bioprocessing program.	 Similarly, the possibility of establishing risk-sharing O 	 y
cooperative arrangements between industry and NASA for space bioprocessing
R&D was not understood by the industrial participants. Many of the companies
asked for additional information. In some cases this took the form of a request for
further visits by NASA personnel to meet with their top level management people
on various aspects of the
	 a b'	 ro	 t	  
	 space ioprocessing p gram. Mos  often
 the request was
made for additional data on completed or planned experiments, or data on the y^ I
NASA owned equipment that might be available for use in cooperative experi-
ments. Based upon this finding it is recommended that NASA develop and maintain G	 ^
several databases for use in supporting further marketing activity to these
m ld	
( /
industries. For exa	 a database could cover all of the planned and/or
contemplated space bioprocessing experiments and include information such as
titles, abstracts, Principal Investigation identification and references. Another
J
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database could include' descriptive and performance information on space
r—
processing equipment that has been developed by NASA. In addition to the two
databases mentioned above, a third database containi t+ ?nformation on the Get
Away Special experiments would be of help in responding to the type of requests for
additi- al information that were raised in the meetings conducted in this study.
These databases will prove useful to NASA customer representatives in responding
to requests from industry concerning prior of planned experiments, and/or the
availability of existing NASA equipment to support future industry experiments
programs.
As an initial step in developing these databases, it is recommended that
NASA conduct a comprehensive review and study of the availability of the
information needed to support these databases. This should include an examination
of the sources and nature of the data, the needs of NASA marketing personnel for
the uses of the information, as well as the formats and alternative mechanizations
for the databases.
In addition to the development of these databases to support future
marketing efforts, it is recommended that NASA follow up the specific requests
for additional information as noted in the individual industry meeting reports
included in Appendix C of this report.
Longer term information transfer programs should also be considers i. These
might include a quarterly newsletter with a swnma-y of the results of Curren
^j o _ (J3^- ^Jprograms and/or discussion of plans. The newsletter could also provide
	 V—
convenient format forriodicall ^ restating the	 5pe y g opportunities for cooperativ
programs. An annual conference or workshop specifically on the subject of space
bioprocessing might also be a good method of information transfer. The confer-
ence might be hosted by a university under the auspices of NASA, or it might be
L^bg2
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held in conjunction with Industrial Biotechnology Association or Pharmaceutical
	
LVI
Manufacturers Association meetings.
5.2 Remove Some of the Uncertainty Concerning the Cost of Operations in the
Space Environment
As might be expected, the issue of the cost of operating a production facility
in space came up in nearly every meeting. In some cases there was a tendency to
discard the possibility of using the space environment for the manufacture of
production quantities of biological or pharmaceutical materials because of the
expectations of very high costs. In other discussions, concepts that might squire
repetitive flights were dismissed because of the expectation of high costs. With
this perception, it is not likely that industry will consider tha use of the space
environment for R&D that could lead to a need for a space-based production
facility or for repetitive flights. In nearly all of the contacts made in this study
the industry participants had no real information concerning the cost of operating
in the space environment. The perception of the high cost of space operation may
be difficult to correct, as the costs most often given in the press for the use of the
Shuttle: are either the cost of the vehicles to the government or the cost to a
customer for the occupancy of the full payload bay. It is not likely that the kinds
of experiments suggested by the companies that participated in the study will lead
to a need for the full payload bay.
At the time of this study pricing policies have been published for the Get
Away Specials and toe= p iyloaa bay. Pricing policies have not been approved for
commercial use of ether payload areas likely to be used for bioprocessing
experimentation, such as Spacelab and the Capacity for Opportunity Payloads. To
clarify this situation it is recommended that NASA devell op policies for commercial
use of these other payload areas, and that pricing policies for these payload areas
be published. As discussed in Sections 4.3.5 and 5.2, it is possible that the current
r.
r.
^U
64
lack of information and the presence of a considerable quantity of misinformation
is an inhibiting factor in consideration of the use of the space environment by
industry. Moreover, as pointed out in Section 4.3.2, few of the industry partici-
pants were aware of the opportunities for cooperative programs that could reduce
the cost of space-based research and development. To support future marketing, it
is recommended thQ'NASA develotric cost/price model for the
use of these other payload areas such as Spacelab and Capacity for Opportunity
Payloads. This model, along with improves; information on possible cooperative
arrangements between industry and NASA., can then be used by NASA customer
representatives to help industry develop a better perception of the true cost of
using the Shuttle for space bioprocessing.
5.3 Marketing Strategy
The fact that direct contact with pote . tial customers can be an important
and productive part of a NASA marketing strategy to sell access to space and/or
the use of the space environment to the biotechnology and pharmaceutical
industries is reinforced by this study. However, i' must be realized that the use of
a particular marketing approach must be care-eully integrated into an overall
marketing strategy, and that what is deemed to be an _. ,, -opriate strategy and
t
approach today may need to be adjusted in the future to a changing perception of
national needs an., the marketplace. While it is clear that the industries contacted
in this study are receptive to a direct marketing approach, this does not imply that
direct marketing should i),e used to the exclusion of all other marketing
mechanisms. In fact, one of the findings of this study is the need by the industries
contacted for additional information.. Otter mechanisms such as publications,
4*
seminars, presentations of scientific results at meetings are necessary to support a
direct marketing approach. Follow-up with potential customers is an important
•f"
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part of the direct marketing approach. In order to support both the initial contact
and the follow-up in direct marketing it is important that NASA develop the tools
for use by their marketing personnel. These include presentation material of the
type used in this study, as well as the various databases that can be used in the
follow-up activity.
All of the above are elements of a marketing plan. In the absence of a
marketing plan it is difficult to set goals or objectives for the marketing effort, to
put in place the process to fulfill these goals or to even measure progress along the
way. Based on the results of this study it may be concluded that the process of
marketing to the biotechnology and pharmaceutical industries is a long-term
effort, and that a carefully thought out plan for conveying information and
following up with these industries is an important part of a future marketing
effort. For this reason it is recommended that NASA consider the formulation of a
long-term marketing plan for the biotechnology and pharmaceutical industries, and
that consideration be given to direct marketing, along with other marketing tooi.s,
in the implementation of this plan.
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APPENDIX A
LETTER TO CANDIDATE COMPANIES
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January 12, 1984
Dr. Zola Horovitz
E.R. Squibb
Box 4000
Princeton, NJ 08540
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NINE HUNDRED STATE ROAD
PRINCETON, NEW JERSEY 08540
TELEPHONE 609924-8778
TELEX 642.215
Dear Zola:
This letter will confirm our telephone conversation on January 11, 1984.
r-
' ECON, Inc., as a contractor to the National Aeronautics and Space Administration
(NASA), is conducting a study of the potential use of the space environment by the
U.S. pharmaceutical and biotechnology industries. A focus of the study is the
access provided to the space environment by the NASA Space Shuttle. The
principal objective of this study is to supply NASA with an independent assessment
of the perceptions and needs of these industries concerning the potential use of the
space environment for the processing of biological and pharmaceutical materials.
In order to perform this study, we plan to meet with a selected group of companies
that may have an interest in the long term in the use of the space environment.
We believe that E .R. Squibb may be such a company, and we solicit your
cooperation and participation. The meeting will provide for an exchange of
information. We will describe our understanding of the background and experience
gained by NASA in their experimental work with the separation of biological
" materials in the space environment, the capabilities and facilities that can be made
available by NASA to support this type of research and development as well as the
range of working relationships that are possible with NASA. Through further
a	 discussion with you, we would then hope to gain additional insight into your
attitudes, expectations and perceptions concerning the possible use of the space
environment to support your research and development needs. These insights will
~ be particularly useful to us in developing recommendations for actions that might
be taken by NASA to make the use of the space environment more attractive to
your industry.
. It is our plan to hold individual meetings with the companies that participate in this
study during February 1984. The meeting will be held at your facility, or at any
location that is convenient to you. The duration of the meeting will be about two
hours. After we complete our assessment of the results of the meetings, we may
find it helpful to have a follow -up telephone conversation. Needless to say, we are
not seeking proprietary information, and will treat any information that you would
prefer to remain confidential (including the name of the company and respondent)
as such in our final report to NASA.
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Your participation in this study has two advantages. First, you will have an
opportunity to get an overview of the prior work supported by NASA, and the
capabilities of NASA facilities to support research and development in the
separation of biological materials in the space environment. Second, you have an
opportunity to provide an important input to the development of our recommenda-
tions to NASA concerning actions that they might take to make the space
environment more accessible and productive to your industry. Upon final approval
by NASA for distribution, we will provide you with a complimentary copy of the
final report on the study.
I will call you in the next few days to answer any questions that you may have and
to firm up the arrangements for a meeting in early February.
Best Regards,
B.P. Miller
President
BPM/md
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APPENDIX B
.D IN MEETINGS WITH BIOTECHNOLOGY
HARMACFIITTrAL. COMPANIFC
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APPENDIX C
NOTES FROM MEETINGS WITH BIOTECHNOLOGY
AND PHARMACEUTICAL COMPANIES
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INTEROFFICE MEMO
TO:
FROM:
Project File
B. P. Miller '7^
SUBJECT: Meeting with BioTechnica International,, Inc.
DATE:
	
February 6, 1984
I. Details of Contact
Name and Address:	 BioTechnica International, Inc.
85 Bolton St.
Cambridge, MA 02140
Date	 2 Feb.. 1984
Telephone	 (617) 864-0040
Contacts
	
Thomas Coor, Vice Chairman of the Board
Lynn C. Klotz, Vice President, New Product Development
John Marsden, Vice President, Marketing and Sales
2. Background
BioTechnica was selected as a participant in this study on the recommendation
o4 Karvey Price, Industrial Biotechnology Association.
BioTechnica is a young company, 2 1/2 years old. Their scientific staff is
drawn mainly from MIT and Harvard. They had a public stock offering in
March 1983. Their main areas of business are research and development
in the areas of genetic engineering, recombinant DNA and fermentation
technologies to develop and produce new strains of microorganisms and
altered crop plants. Major areas of business at the present time are the
development of advanced microbial production systems for the food,
beverage, chemical and pharmacuetical industries, and improvement of plant
molecular biology and nitrogen fixation technologies for agricultural
applications. Sales in 1983 were "less than $.5 million" and are
anticipated to be in the "neighborhood of several million" in 1984. At
the present time the company is engaged only in R&D and none of these
products have reached the production stage. Their first product will
enter the marketplace in 1985, with a second in 1986. Full time staff
at present consists of about 65 people, of which 23 hold PhD's.
1	 3. Comments
BioTechnica had little prior knowledge concerning the separative experiments
conducted by NASA and MDAC. Neither was BioTechnica familiar with
+..
127
- 2 -
NASA ground research facilities, nor the various possibilities for the
use of the Shuttle for experimentation. Moreover, BioTechnica had no
prior knowledge of the possibility of cooperative working agreements with
NASA.
Dr. Klotz indicated that the free flow electrokinetic separation tech-
niques that have been used by NASA (and appear to be used by MDAC) are
indeed bothered by sedimentation and convection effects in a unit-9
environment. Because of this, according to Or. Klotz, other techniques
such a:, gel electrophoresis and density gradient electrophoresis have
been developed to get around these problems. These and other laboratory
techniques are satisfactory for the production of microgram quantities
for analytical purposes. Because of this, Dr. Klotz said that it was
his belief that there might only be a narrow window for the use of the
zero-g environment. To illustrate this point Dr. Klotz described a
simple model for the kind of work performed by BioTechnica:
1. Bench Scale
	 READ
	
Obtain analytical samples of the
product at any cost.
2. Scale Up	 Development
	 Obtain 102 to 5001 samples at acceptable
cost and demonstrate feasibility of
process or produce.
3. Producticn	 Economic factors dominate.
It was his belief that present laboratory techniques were adequate for the
first step and that the use of the space environment might enter at the
second or third steps. In our discussion we built the following simple
decision tree:
(1) will zero-g help	 No
l Yes
(2) can zero-g process be designed----4- No
Yes
(3) can a space shuttle experiment be developed
	 No No
Yes
(4) develop space process -- .No
IYes
According to Dr. Klotz and Dr. Coor there is feedback from (4) to the
preceding ste ps in terms of the economics. It would be necessary to
demonstrate the economic advantage of space processing (an elegant
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solution) as opposed to a more brute force approach on the ground. An
additional restriction would be the fact that the product must have a high
$/mass ratio, otherwise the reasons to use the space environment are not
apparent.
4. Actions
BioTechnica would like to obtain the following additional information:
(1) A list, by title of get-away specials with name and affiliation of
PI. They are interested in seeing how others are rsing this low
cost mode of experimentation.
(2) More information on the work done by Washington University for MDAC.
(3) Somr insight into how they might get MDAC to run samples for
Bio"rechnica in the MDAC CFE device.
Additionally, is was suggested that the development of space processing
might be furthered if NASA were to sponsor additional fundamental research
in space bioprocessing at the university level and b y the cresentatinn of
results at international meetings such as Bio-Tech 84 (to be held in Wash.,
DC, Sept. 1984).
5. Conclusion
This contact had virtually no prior knowledge of the space bioprocessing
program or the opportunities for experimentation using the Shuttle. As
a result, they were not inclined to think in terms of the use of the
space environment. The meeting stimulated their interest and resulted
in requests for additional information. However, they remain skeptical
about the use of the zero-g environment to make separations economically
and competitively with earth-based techniques. The possible use of low
cost, self-contained payloads (get-away special) seemed to be of most
interest.
E;dLn
oeene
INTEROFFICE MEMO
TO:	 Project File
FROM:	 B. P. Miller
SUBJECT: Meeting with Smith Kline b French Laboratories
DATE:
	
February 10, 1984
1. Details of Contact
Name and Address:	 Smith Kline b French Laboratories
1500 Spring Garden St.
P.O. Box 7929
Philadelphia, PA 19101
Jate	 6 Feb. 1984
Telephone	 (215) 751-5500
Contact	 Dr. George Poste, Vice President,
Research and Development
2. Background
Smith Kline was selected as a participant in the study on the basis of the
fact that they are a major manufacturer of pharmaceutical, laboratory and
medical electronics products. Further, based on information available at
the start of the study, Smith Kline is not currently involved with NASA
and 'isnot one of the companies that had been contacted by the contractors
working for NASA on the space station follow-on activities.-
3. Comments
Dr. Poste was knowledgeable about NASA work in space bioprocessing. He said
that he derived his information from sources such as the general press, Con-
gressional Testimony and NASA Tech Briefs. He recalled that the President
of Smith Kline (Dalby) had been approached by NASA a few years ago in con-
nection with space bioprocessing. He could not recall the details of the
contact, but it was clear that there was a residual negative reaction to
whatever proposal had been made. Smith Kline had also been approached to
sponser a high school science "get-away special." They declined to do so
on the basis of the fact that it was their opinion that the proposed high
school experiment lacked scientific merit. Smith Kline is not currently
involved with NASA at any level, and Dr. Poste did not appear to be aware of
the opportunities for cooperative working relationships (i.e. JEA's, etc.)
with NASA. According to Dr. Poste, informal discussions had been held at
Smith Kline concerning the possible use of the space environment, but that
the subject had never been formally considered. Several times during our
interview Dr. Poste stated that he believed that the NASA space bioproces-
sing program suffered from excessive "hype." He cited the President's
	 ,
(*I
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budget message, in particular the remarks about using a space station for
the production of new drugs as an example of promises that are not based on
substance and which are bound to produce a negative reaction in the indus-
try. He said that "the government is ignorant of what industry needs and
industry is ignorant of what NASA has to offer."
Dr. Poste then discussed issues relating to the processing of different
kinds of biological material in the space environment. The catagories
that he mentioned were;
e	 Pharmaceuticals - micromolecules, molecules,
marcromoloecules or cells
9	 Diagnostics and biosensors
He said that there were many factors that worked against the use of the
space environment for the processing of pharmaceutical materials. First
was the issue of cost. According to Dr. Poste, the additional increment of
R&D cost associated with the use of space might make the product not eco-
nomically feasible. Dr. Postesaid that scale, or the ability to produce
the material in sufficient quantity, was also a major factor against the
use of the space environment for processing pharmaceut i cals. He said that'
the evaluation of a product for acute therapy (for reasons of therapy,
safety, formulation,bioavailability and storaa_e) might require several
hundred kilos of material. Other issues that were raised by Dr. Poste
included the timetable ( long lead time) for delivery of payloads prior
to launch and the lack of special handling facilities for biomedical
payloads prior to launch and upon immediate return from orbit. He voiced
two concerns; namely, the production of this quantity of material in
the space environment and the cost of producing this quantity.
Space could be important in the preparation of diagnostic and biosensor
analysis materials. Their applicatiols require smaller quantities of high
$/mass ratio enzymes that could :onceivably be manufactured economically in
space.
He stated that electrokinetic separation techniques are not that important_
to the classes of materials that are used by Smith Kline, and that affin-
ity chromotography separation solves the convection and sedimentation prob-
lems seen in electrokinetic separative technicques. Affinity chromotog-
raphy can be scaled up.
4. Actions
Dr. Poste would like to obtain additional information on "get-away srecials."
He would like to have a list of experiments, abstracts and PI identifica- v
tion. He would also like to be kept aware of scientific progress in space
bioprocessing.
S. Conclusion
This contact was pretty much up to speed on what has been done to date in
space bioprocessing, but was not knowledgeable about the possibility of
cooperative working arrangerieits with NASA. His discussion with me pro-
jected a degree of professional conservatism concerning the use of the
4^
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space environment and a negative reaction to some of the PR concerning
the possible benefits of the space environment to the pharmaceutical
industry. The thought of the possibility of conducting R&D on a small
scale through the "get-away special" seemed to be attractive to Dr. Poste,	 s,1
although his interest here may be aimed at getting up to speed on the
scientific use that is being made of the "get-away specials."
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TO:	 Project File
FROM:	 B. P. Miller
SUBJECT:	 Meeting with Damon Biotech
DATE:
	
February 13, 1984
{
1. DETAILS OF CONTACT
(
Name and Address: 	 Damon Biotech, Inc.
119 Fo-_Irth Avenue
Needham Heights, MA 92194
Date:	 9 February 1984
Telephone:	 (617) 449-6002
Contacts:	 Dr. R. Dana Ono, Manager, Technology Resources
Dr. Brandon Price, Product Director, Cell
Products
Ms. Marcia Amsterdam, Vice President, Public
Information
2. COMMENTS
D^rtior, Biotech was selected as a participant in this study on the
recommendation of Harvey Price of the Industrial Biotechnology
Association.
Damon Biotech is a subsidiary of the Damon Corporation that went
public in 1983 and raised about $40 x 10 through a public issue.
Damon Biotech is still about 70% owned by the Damon Corporation.
Damon Biotech has developed a proprietary technique called ENCAPCEL
that facilitates the high density growth of cells and gives product
yields as much as 1,000 times greater than other methods. ENCAPCEL
is being used to manufacture production quantities of monoclonal
antibodies such as Interferon. Damon Biotech has entered into a
,joint development agreement with the Nationa l, Cancer Institute to
conduct clinical trials of cancer treatments using ENCAPCEL. The
first test involves the use of monoclonal antibodies in the treatment
of B-cell lymphomia cancer.
WWI
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The agreement with the National Cancer Institute was announced
19 October 1983,	 In addition, Damon Biotech is conducting animal
studies of the use of ENCAPCEL for the treatment of diabetes. In
this case, healthy pancreatic cells are encapsulated and are transplanted
to a diabetic host.	 The healthy cells then act as a self adjusting
insulin source.
Market applications of current interest to Damon Biotech are listed
below:
Quantity of
Antibody Antibody	 4
Market	 Function Applications Needed
ttherapeutic
	 Destruction of B-cell Lymphoma
diseased cells T-cell Lymphoma
Colon cancer
Autoimmume
diseases
Immunosuppression Organ transplan-
tation ograms
per
Prug targeting Cancer therapy product
Antibiotic delivery
In vivo neutralize-	 Bacterial	 toxins
Lionof toxins Chronic viral
infections
Industrial	 Separation of Protein purifica- Kilograms
Purification	 product from tion	 (e.g., per
contaminants interferon,
growth hormone
product
Diagnostic	 Diagnosis of disease Diagnosis of tumors Kilograms
Imaging	 by specific mono-	 Evaluation of tumor per
clonal antibody	 chemotherapy	 product
coupled to radio-	 Assessment of heart
isotopes or non-	 damage
isotopic markers
Laboratory	 Improved specificity All immunodiagnos- Grams to
Diagnostics
	
of immunodiagnostic	 tic kits including kilograms
kits
	
cancer, infectious per product
diseases, hormone
levels
Source: Damon Biotech Annual Report 1983
V5
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At the present time, Damon Biotech has a staff of about seventy
people. They are constructing the world's largest monoclonal antibody
facility that will come on line in May 1984. At the present time,
it appears that Damon Biotech uses the ENCAPCEL technique to produce
products for other companies (i.e., Interferon for Hoffman LaRoche).
According to Dr. Ono, they are working on other products using the
same technique for the treatment of diabetes and cancer, as well as
for the controlled release of pharmaceutical materials.
3.	 COMMENTS
Dr. Ono and Dr. Price said that they were both very interested in
space bioprocessing, but that they knew very little about the NASA
program. They indicated that their main sources of information were
the general press. Dr. Price said that he had a classmate at JPL
and that he often called his classmate when he had questions about
the space program. Neither Dr. Ono nor Dr. Price were aware of the
possibility of engaging in a cooperative R&D program with NASA.
Following our discussion of the NASA program, I was told that Damon
Biotech could use additional information on the scientific aspects
of the NASA program. Specific requests were made for information
about the "get away special" experiments, and concerning any work
that NASA might have done on the productivity and fusion frequency
of hybridomas in zero g. I was asked if it was possible for NASA
to provide a speaker well versed in the science aspects of the space
bioprocessing program to talk to their Scientific Board consisting
of top level research scientists from MIT and Harvard.
Possible applications of the space environment that were suggested
in our meeting included the investigation of cell efficiency (pro-
ductivity and fusion frequency) in the zero g environment and the
use of electrophonesis to separate contaminants from monoclonal
materials. Cell efficiency seemed to be of major interest, and
Dr. Ono indicated that if the absence of gravity improved efficiency,
it might be possible to produce very valuable products in small
scale facilities.
Dr. Ono mentioned that he had brought up the possibility of using
the space environment at a staff meeting and that the comments
were favorable. However, their resources did not permit them to mz..ve
in the direction of space research at that time. I was told that
the people at Damon Biotech need more information on how to do business
with NASA. "Where is the bridge between NASA and the biotechnology
companies?"
1
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	4.	 ACTIONS
(1) Provide a speaker who can talk knowledgeably about the science
aspects of the NASA space bioprocessing program to meet with
their Science Board.
(2) Follow up our question concerning any NASA research on the effects
of zero g on cell efficiency.
(3) Provide information on use of "get away specials" including
titles, abstracts, and Principal Investigator identification.
(4) What is MDAC posture on processing material supplied by Damon
Biotech in their electrophoresis experiments in the Shuttle?
What would it cost?
	
5.	 CONCLUSIONS
Dr. Ono and Dr. Price appeared to be interested in exploring how Damon
Biotech might use the space environment. There is a need to supply
them with additional information and to follow up on the actions
noted above. Neither of the participants in the meeting appeared
to have much prior knowledge concerning the NASA program or the
possibility of engaging in a cooperative R&D effort with NASA.
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INTEROFFICE MEMO
TO:	 Project File
FROM:	 B. P. Miller
SUBJECT:	 Meeting with E. R.	 Squibb
4 DATE:
	
February ls, 1984
1.	 DETAILS OF CONTACT
IL
Name and Address: E.	 R.	 Squibb
P. 0. Box 400
Princeton, NJ
	
08540
Date: 1.0 February 1984
K-i-
r Telephone: (609) 921.4000
? Contacts: Dr.	 Zola Horovitz, Vice President, Research
and Development (Squibb)*
Dr. Grant Gibbons, Product Development and
Planning Manager (Squibb)
Mr. Hank Bauer, Director, Manufacturing Opera-
tions	 (Squibb)
Mr.	 Glenn A.	 Brewer, Assistant Director, Analyti-
cal	 Research (Squibb)
Dr.	 Klaus Florey, Director, Analytical	 and
Physico-Chemical	 Research,	 (Squibb Institute
for Medical Research)
Dr. George B. Mackaness, President (Squibb
Institute for Medical	 Research)
Mr.	 J.	 D.	 Pipkin,
	
Senior Research Scientist,
Phari;aceutical	 Research and Development
(Squibb)
Mr. Mike Varia, Director, Strategic Planning
(Squibb)
2.	 BACKGROUND
rSquibb was selected as a participant in this study on the basis of
the fact that they are a major international manufacturer of pharma-
ceutical	 products, with subsidiaries with product lines in laboratory
ki
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and medical electronics. Further, based on information available
at the start of this study, Squibb was not involved with NASA and
is not one of the companies that has been contacted by the contractors
working on the Space Station follow-up activities.
3.	 COOMENTS
:,; addition to the author of this report, Dr. Edwin Dupnick of
EON and Ms. Helene Najduk of NASA also participated in this meeting.
It was clear from the meeting that Squibb had little prior knowledge
about the work that had and is currently being performed by NASA
in the field of space bioprocessing. Nor did the participants in
the meeting have prior knowledge about the possibility of establishing
cooperative arrangements with NASA (such as a JEA). It was indicated
that perhaps two or three years ago Squibb had undertaken a contract
for NASA in support of an RTG development, but that work was outside
of the pharmaceutical area.
Their initial reaction to our presentation was to ask how they could
obtain additional information on past and planned space bioprocessing
that is being performed for NASA. We were asked about the availability
of scientific reports, abstracts, and bibliographies coverin g the
work performed by NASA and its contractors. We were asked if NASA
could provide a speaker to talk to senior management of Squibb
about the scientific results of experiments conducted to date and
about the scientific goali of future planned space bioprocessing
experiments. In subsequent discussion, we were told by Squibb
(Dr. Horovitz) that two types of meetings might be worthwhile; the
first for a small meeting of high level scientific personnel, and
the second for a large meeting of Squibb middle management. 1.4e
were further asked if NASA could make available to Squibb an index
or catabase of literature that has been published on the scientific
and technical aspects of space bioprocessing. When I showed one
of the participants a paper that had been published by the American
Astronautical Society on an electrophoresis experiment in STS-3,
we were told that publications that deal with astronautics are not
usually read by people in the pharmaceutical field.* It was suggested
that articles of this sort might better be published in Science
or Nature. One of the participants had the notice for the forth-
coming AIAA sponsored meeting on space bioprocessing in Houston
that he had received from the Pharmaceutical Manufacturers Association.**
E* lectrophoretic Purification of Cells in Space: Evaluation of Results
from STS-3, Burton E. Sarnoff, M. Elaine Kunze, and Paul Todd. American
Astronautical Society, 83-212.
**Space Bioprocessing Seminar, 1, 8 March 1984.t
s
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It was suggested that NASA publish more in journals that the pharmaceutical
industry normally uses, and that more meetings of the sort planned
for Houston should be held.
With the exception of diagnostic materials, the products made by
Squibb are usually produced in large volume, i.e., tons of material.
The participants in the meeting found it difficult to visualize how
a plant that could produce tons of pharmaceutical materials per year
could be made economic in the space environment. For example, it
was said that Squibb had just spent the cost of one shuttle flight
(i.e., about $70 x 10 6 ) to build a production facility that would
hopefully last forty years. I responded that within a decade it
may be possible to build a plant in space that would last forty
years; however, the high cost of transporting large volumes of material
to and from space was recognized as a deterent to large volume produc-
tion in the space environment.
Several of the Squibb people present suggested that the zero g attribute
of space was of interest to them for R&D purposes. For example, it
was suggested that it might be possible to separate a cell population
in space that is difficult to separate on earth. The separated cells
could be brought back to earth and then replicated. This concept
might be applicable for diagnostic materials. It was also suggested
that the improvement obtained by conducting separations in the space
environment might be a possible service business. In this case,
the operator. of the separative equipment in space could sell services
to pharmaceutical companies for purposes such as determining the
purity of a new drug, identifying small (.01 1/0) impurities, or producing
analytical or preparative quantities of a material. The radiatoon
and cryogenic temperature attributes of the spa r e environment did not
elicit much interest, although one of the Squibb participants asked
if NASA had conducted freeze drying experiments in the space environ-
ment.
It was pointed out that from their perspective, commercialization
means large volume production, not simply the use of space for com-
mercial purposes. It was difficult for them to postulate on how they
might use the space environment since they had not had much prior
information, nor was the use of the zero g environment something
that they routinely thought about. Given their present state of
knowledge, it was clear that the use of space would be considered
only if there was no other way to accomplish what had to be done.
4.	 ACTIONS
(1) Provide a speaker well versed in the science aspects of the
space bioprocessing program to talk to a small group of senior
scientific people at Squibb.
f
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(2) Provide a more general engineering oriented speaker to talk to
a large meeting or Squibb middle management at a Management Club
dinner meeting.
(3) Provide an index and/or database of publications on space 	 _44
bioprocessing.
(4) Provide data on the experimental use of the "get away special"
experiments such as titles, abstracts, names, and affiliation
of Principal Investigators.
(5) Provide data on NASA owned space bioprocessing equipment that
might be available for experimental use by Squibb in the shuttle
program.
5.	 CONCLUSIONS
We met with a large group of senior R&D and R&D management personnel.
It was clear that they knew little about the NASA space bioprocessing
program, nor did they have any prior knowledge about the possibility
of cooperative working relationships (JEA) with NASA. In fact,
one of the Squibb participants stated that their normal method of
obtaining information on NASA programs would be to query the IAC
at the University of Pittsburgh. Although no specific experiments
were suggested, there seemed to be a strong interest on the part of
the Squibb participants in obtaining follow-up data that might help
them better understand how they might use the space environment.
BPM:nw
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INTEROFFICE MEMO
t
TO:	 Project File
FROM:	 B. P. Miller
SUBJECT: Meeting with Merck, Sharp and Dohm
DATE:	 March 2, 1984
1. DETAILS OF CONTRACT
Name and Address:
Date:
Telephone:
Contacts:
2. BACKGROUND
Merck, Sharp and Dohm Research Laboratories
Division of Merck do Co,, Inc.
P.O. Box 2000
Rahway, NJ 07065
17 February, 1984
(201) 574-6447
Mr. James Lago, Vice President for Development
and Process Chemistry
Dr. Lewis Mandel, Senior Director, University/
Industry Relations
In addition to the above, Ms. Helene Najduk of
NASA Headquarters also participated in this
meeting.
Merck was selected as a participant in the study on the basis of the fact that
they are a major manufacturer of pharmaceutical products. Moreover, at the
time of their selection, it was believed that Merck was not involved with
NASA and it not one of the companies that has been contacted by the
contractors working for NASA on the space station follow-on activities.
3. COMMENTS
Mr. Lago had heard a presentation by MDAC at a SNOWMASS meeting
several years ago and Merck had also participated in a study group with
Rockwell. The attitude that was projected is that Merck has been involved
and is up to speed on the subject of space bioprocessing. Mr. Lago indicated
that space bioprocessing has been discussed within Merck but that they have
not been able to come up with anything that looks like an economically
feasible process.
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Mr. Lago stated that he was not sanguine about the use of electrophoresis in
space as a general purpose separation technique of commercial significance.
For most applications, there are more economic methods available. He
indicated that separation methodologies have increased in number and in
effectiveness in recent years. Further, advances in biotechnology have
simplified separation problems through the ability to preferentially produce
desired biological molecules as well as by providing powerful separation
techniques. Procedures now in use in their laboratories are adequate for
current projects. Mr. Lago said that Merck has a research and development
staff of about 3,000 people and that the individual scientists follow the
literature in their own areas of interest. No specific attempt is made to
obtain NASA publications and no specific individual is responsible for
following the activities of NASA in space bioprocessing. Dr. Mandel pointed
out that Merck probably does not get aerospace journals and would not see
the result of NASA work unless it was published outside of such journals.
There was interest on the part of Merck in receiving additional scientific
information, information about experiments performed to date by NASA and
others or characteristics of available equipment that could be used, but more
for background information than for problems needing solution. In response
to a specific question, Mr. Lago said that at this time Merck has no
separation problems that would be benefited by electrophoretic processing in
a micro gravity environment and therefore would not be interested in using
NASA or MDAC separative equipment to process samples furnished by Merck.
ACTIONS
None.
CONCLUSIONS
There is little interest at Merck at the present time in space processing
because no benefit is seen for current research and development programs.
The open literature is followed, and if opportunities not now envisioned
develop, the interest would increase.
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INTEROFFICE MEMO
TO:	 Project File
FROM:	 B.P. Miller
SUBJECT: Meeting with Upjohn
DATE:	 March 6, 19 84
I. DETAILS OF CONTACT
Name and Address:
Date:
Telephone:
Contact:
2. BACKGROUND
The Upjohn Company
7000 Portage Road
Kalamazoo, MI 49001
February 22, 1984
(616) 323-4000
Dr. Jacob Stucki, Vice President
Pharmaceutical Research and Development
Upjohn was selected as a participant in this study because they are a major
U.S. developer and manufacturer of pharmaceuticals. Additionally, Dr.
Stucki is Vice Chairman of the Pharmaceutical Manufacturers Research
Association and Development Steering Committee. Our contact at the PMA,
Mr. Chuck Cleveland, further indicated that Dr. Stucki would be a good
person to talk to in this study.
3. COMMENTS
' Dr. Stucki has given testimony to Congress on behalf of the proposal to
establish (and fund at the outset with NASA money) a university research and
development center that specializes in zero gravity bioprocessing. Dr. Stucki
said that he was familiar with the MDAC, work in continuous flow electro-
phoresis, and that he had attended a PMA meeting where someone from
MDAC had conducted a briefing on their work (I believe that this was the
PMA R&D Annual Meeting on April 27-30, 1983. Presentations were made by
Mr. Joseph Coleman of MDAC and Mr. Louis Hemmerdinger of Grumman at
this meeting).
nr. Stucki indicated that he had a strong personal interest in space
bioprocessing and that he had an intuitive belief that it could offer a new way
to get some interesting things. However, he added that space bioprocessing
was not a basic goal for Upjohn, and that its value to Upjohn would depend
upon the problem that they were trying to solve.
As an example of the potential value of space bioprocessing, Dr. Stucki
mentioned a cell cycle experiment that he believed was planned for the
Shuttle in 1986. The purpose of the experiment is to examine the effects of
cell cycle inhibitors on cell performance. He seemed to recall that the PI is
an Astronaut who is also an onocologist.
He indicated that he had been instrumental in getting Dr. Alan J. Parcells to
participate in the March 1984 NASA/AIAA space bioprocessing meeting in
Houston, TX. He felt that the involvement of Parcells was appropriate
because Parcells was involved in the development of pilot plant processes to
produce preparative quantities of interesting materials that Stucki identifies
in the laboratory. Dr. Stucki said that his laboratory people can figure out
ways to get analytical quantities (milligrams to grams) of almost anything,
but that this statement could not be made about larger quantities (prepara-
tive quantities).
According to r>r. Stucki, the J&J involvement with MDAC is an aberation and
not typical of what could be expected from the pharmaceutical industry. J&J
is much more diversified than most pharmaceutical companies and is made up
of many small cost centers. lJpjohn is a more typical pharmaceutical
company, and in Upjohn the driving factor is to find chemical entities that
have potential market value. There was some speculation on his part
concerning how J&J got involved wi,h MDAC. He suggested that it might
have happened because of fortuitous contact between top level executives in
the two companies. In this connection, Dr. Stucki mentioned that someone
from NASA had approached their President but that Upjohn did not see
anything of interest in the NASA proposal.
Dr. Stucki pointed out that from the viewpoint of the pharmaceutical
industry, what MDAC and NASA had to offer was a means to an end, but not
the end itself. As far as Dr. Stucki was concerned the end was the chemical
or biological entity. He viewed the space industry as driven by a desire to
sell space technology, while the pharmaceutical industry is driven by the need
to find new marketable products. He indicated that as a process, the
separative work that is typified by the MDAC effort must fit in as a process
into either (1) new entity identification or (2) new entity product. It was his
view that the separative technology was probabaly of greater interest to
production.
Dr. Stucki indicated that cell cycle performance and the growth of protein
crystals were two interesting areas of possible investigation for space
bioprocessing. tie said that separative technology could also be interesting
for the production of analytical quantities in space if the device used could
yield improved resolution. However, it was his perception that the resolution
of the MDAC device was not very good. I pointed out to him that NASA was
developing an isoelectric focusing machine (Dr. Bier, Univeristy of Arizona)
and that the Bier machine was said to have improved resolution.
He said that the best way that he could think of to advance the NASA j
program was to get technical data on the NASA work and capabilities in front
of their laboratory people so that their people would begin to view space as
an alternative for either RECD or production.
	 He specifically suggested that
it would be useful to have information on space bioprocessing devices at the
annual Pittsburgh instrument manufacturers meeting and technical exhibit.
He stressed the fact that the pull for the use of space bioprocessing had to
 come from their middle level managers and researchers - not from him, and
that these people needed additional information if they are to consider space
as an alternative.	 i "s^`
^.	 4.	 ACTIONS X17,tip''
(1)	 What are the expected or measured operating characteristics of the
^•	 isoelective focusing device that has been developed by Dr. Bier at the
University of Arizona?
(2)	 Make available technical information on space bioprocessing experi-
ments in a form that can be easily accessed by laboratory R&D
personnel.
5.	 CONCLUSION
Dr. Stucki has had more prior contact with the space bioprocessing program
than any of the other contacts made in this study. Although he was not able
to identify any specific applications for space bioprocessing within Upjohn, he
has a strop
	belief that the NASAg	 program is valuable and of potential
benefit to the pharmaceutical industry.
	 Particular applications that were
suggested were protein crystal classification, isolation of new substances of
interest and production of preparative quantities. ^
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INTEROFFICE MEMO
TO: Protect File
FROM:	 B.P.Miller
SUBJECT: Meeting with Genex Corporation
DATE:
	 March 8, 1984
1. DETAILS OF CONTACT
Name and Address:
	
Genex Corporation
16020 Industrial Drive
Gaithersburg, MD 20877
Date:	 February 24, 1984
Telephone:	 (301)238-0552
Contact:	 Dr. Kevin Ulmer, Vice President
Advanced Technology
2. BACKGROUND
Genex was selected as a participant in this study on the basis of the
recommendation of Harvey Price, industrial Biotechnology Association.
Genex was established in 1977 and had a gross revenue of $3,203 , 193 in 1982,
with total assets of about $32 million. The major emphasis of the company
has been the development of proprietary products for food processing,
industrial and commercial applications. The commercial strategy of Genex
has not emphasized pharmaceutical products because of the extensive testing
requirements and the regulatory delays that are involved in bringing pharma-
ceutical products to the market. However, Genex does engage in contract
resear ch and development of various pharmaceutical products including
therapeutic enzymes and therapeutic proteins.
r	 3. COMMENTS
Kevin Ulmer had a good background of knowledge on the space program.
While he was a graduate student at MIT he applied to be a Mission Specialist
on the Shuttle. He is a member of the L-5 Society. He has had discussions
with Dr. Gerald Soffen, formerly the Director of the Life Sciences Division
of NASA Headquarters, on space processing.
lab
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According to Dr. Ulmer, Genex has decided not to become a pharmaceutical
company. He said that only one new pharmaceutical company has come into
being since World War II, namely Syntex. The FDA requirements for clinical 	 ..
trials and testing are too much of an obstacle for new entries. For this
reason, Genex has stayed away from regulated products and has concentrated
their efforts on higher volume (lower unit value) production products.
However, Genex has cloned products such as interferon and urokinase under
contract to pharmaceutical companies. Dr. Ulmer commented that the
separation and purification experiments that are being conducted by NASA
and MDAC in the space shuttle have largely been obsoleted by r,:-ombinant
DNA technology and genetic engineering. It was his opinion that electro-
kinetic separation in zero g might be useful for a few kinds of materials such
as living cells, but it was his c pinion that the NASA research in electrokinetic
separation has not caught up with the new technologies of genetic
engineering.
He suggested that protein crystalography might be a productive area for
R&D. He indicated that there were three aspects that are important in
protein crystalography:
t	 (1) Quantity
i	 (2) Purity
(3) Size
Problems of quantity and purity can be solved on the ground. The space
environment may be helpful in the growing of crystals of sufficient size. At
the present time the characterization of crystals by x-ray cr estalography is
limited by the fact that only a small number of proteins can be grown into
crystals that are large enough. Most protein crystals are smaller than I
millimeter and sizes larger than 1 millimeter are needed for many
experiments. Dr. Ulmer suggested that since larger crystals of inorganic
materials could be grown in space than on the ground, it should be possible to
grow larger crystals of proteins in space than on the ground. If the crystals
could survive the mechanical environment of the return trip they could be
characterized on the ground. If the mechanical environment was too severe 	 i*
and caused the crystals to fracture, it would be necessary to perform the x-
ray crystalography in space. Dr. Ulmer suggested that there would be a
market for the crystals grown in space in a manner similar to the
monodispersed polystryrene latex spheres that were grown in an earlier
shuttle flight.
Dr. Ulmer suggested that it would be necessary for aerospace companies to
take a much more aggressive posture with the biotechnology and pharmaceu-
tical companies if the goal was to involve more of these companies in space
R&D. The biotechnology companies are innovative but do not have much
money, while the pharmaceutical companies have money but are not very
innovative.
	
s	 Dr. Ulmer described a lien
is being established by NB
	a	 on gomery County willF
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State of Maryland may also provide. funds. Several pharmar_euti,:sl
companies. including one of the larger Japanese pharmaceutical companies
(Otsuka) have expressed an interest in participating. The Center would
provide the opportunity for collaborative or proprietary R&D. Tie key
person at the University of Maryland is Dr. Rita Colwell, Vice President for
Academic Affairs (853-6000)
4. ACTIONS
Dr. Ulmer asked the following specific questions:
(1) Can we provide some examples of the cost of development of get !%wa^
special experiments?
(2) What other (other than MDAC) aerospace companies are capable and/or'
interested developing hardware for space bioprocessing? 	 I'
(3) What hardware it currently available that might be used for space !^`
bioprocessing experiments? 	 i
(4) Can we furnish some specific scientific references to work that has
been done or is planned for space in the area of protein crystal growth?
5. CONCLUSION	 ----
Dr. Ulmer was knowledgable concerning the NASA space bioprocessing
program and outspoken about the fact that the current emphasis on
separative R&D was misplaced. He expressed an interest in obtaining
additional information concerning the possibility of using the space environ-
ment for R&D in protein crystal growth.
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I	
TO:	 Project FileI	 FROM:	 B.P. Miller
SUBJECT: Meeting with Biogen Research Corporation
DATE:	 March 9, 1984
1. DETAILS OF CONTACT
Name and Address:	 Biogen, Inc.
14 Cambridge Center
Cambridge, MA 02142
Date:	 February 27, 1984
Telephone:	 (617)864-8900
Contacts:	 Richard Aldrich, Business Analyst
John Smart, Associate Research Director,
Head of Protein Chemistry
Wm.S. Kelley, Vice President for Research
Administration
2. BACKGROUND
Biogen was selected as a participant in this study on the basis of the
recommendation of	 he Industrial Biotechnology Associa-
tion.	 Biogen '	 d the Cambridge, MA facility is	 tµ
headquarters fori
Biogen was just granted an European patent for genetically manufactured
alpha interferon. Their U.S. patent application for alpha interferon is
pending. Biogen has licensed Schering-Plough to market the alpha interferon
in Europe under the trade name of Intron. Their major competition is
Hoffman-La Roche which is testing an interferon product made by Genetech.
3. COMMENTS
Dr. Smart began by saying that Biogen uses electrokinetic separation of the
type that is being explored in the Space Shuttle to obtain analytical
quantities of substances of interest. Once the substance of interest has been
obtained, preparative quantities are obtained using genetic engineering
techniques. In general Biogen lacks the financial capability to put large sums
of m(. ,key into the development of new separation techniques and equipment.
.ti
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They also do not have the technical background to develop space qualified
equipment. However, Biogen might be interested in participating in separa-
tion experiments in space if they could use an existing device and did not
have to build their own separation equipment. The example given by Dr.
Smart was a case where Biogen might provide a sample for separation. The
sample would be resolved into five or six separate proteins of interest, and
returned to Biogen. Biogen would then use the separated materials either as
the basis for replication using genetic engineering techniques, or would use
the sample to obtain structural data on the protein of interest. In the latter
case, x-ray crystalography would be used to characterize the protein.
It was suggested that the space environment might be useful to grow protein
crystals for x-ray crystalography, or to separate specific cell populations.
The latter would require finer resolution than can be obtained on earth. In
the case of crystal growth, the crystals might be used to verify the lot
quality control by crystal uniformity. It was emphasized that the latter
application was not a requirement at the present time and that Biogen was
debating the issue of lot verification with the FDA.
Dr. Kelley pointed out that their main source of information about space
bioprocessing is the Boston Globe (newspaper), and that an easily accessible
database that contains scientific information on space bioprocessing expe: i-
nvents would be of great value. It was also indicated that Biogen w'Luld be
interested in talking to knowledgeabl? people from the scientific side of the
NASA space bioprocessing program.
4. ACTIONS
(1) Can NASA provide a database that covers the science aspects of work 	 ,p
that has been done or is planned in the area of space bioprocessing? 	 \
i(2) Can NASA scientists be made available to talk to their scientific people
about the NASA program? 	
yy
(3) Can information concerning NASA work on sensitive films, filters,
cameras and digital image processing be made available to Biogen?
^N
5. CONCLUSION
Biogen had little previous information concerning either space bioprocessing
or the opportunities for collaborative R&D with NASA. Possible applications 	 U. S
of protein crystal growth and cell • ,aration were suggested as being of
interest, particularly if it was F ,-..ible for Biogen to use an existing
experimental apparatus (or if Biogen did not have to pay for the development
of the experimental device). Specific requests were made for follow-up
information on the science aspects of the NASA space bioprocessing program.
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INTEROFFICE MEMO
TO: Project File
FROM: B.P. Miller
SUBJECT: Meeting with Sepracor, Inc.
DATE: March 21, 1984
1. DETAILS OF CONTACT
Name and Address:	 Sepracor, Inc.
1101 State Road, Bldg. 0
Princeton, NJ 08540
>f
Date:	 March 13, 1984
Telephone:	 (609) 924-3022
Contact:	 Timothy J. Barberich, President and
Chief Executive Officer
2. BACKGROUND
Sepracor was selected as a participant in the study because they are a start-
up biotechnology company that will specialize in separation technology.
Sepracor was founded by Robert F. Johnston Assoc. Robert Johnston is the
founder of both Genex and Cytogen. Sepracor is in the very early stage of
formation. At the present time Mr. Barberich is preparing a business
development plan that Sepracor will take to the venture capital community
to raise seed money for the company.
3. COMMENTS
Sepracor will provide biological separation services to the pharmaceutical
and other biothechnology industries. Sepracor will be based upon membrane
and chromatography technology. Both membrane and chromatography are
used ir separations at the present time. Their concept is what Mr. Barberich
called an active membrane ; nd involves using a membrane that is 100A thick
and thousands of square feet in area.
Mr. Barberich indiated that his knowledge of NASA work in space bioproces-
sing was obtained from newspapers and TV. He was not aware of the
opportunities for cooperative RECD with NASA. He was aware of the
NASA/MDAC/J&J activity and characterized it as "a solution looking for a
problem".
41
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He said that Sepracor as a pre-startup company was not in a position to
undertake cooperative R&D with NASA because of the lack of capital. If
Sepracor was a more mature company with financial reserves available, he
would be interested in exploring several possible areas of R&D concerning the
'	 effects of micro gravity or separation processes.
The areas suggested were:
(1) Magnetic Separation.
Magnetic separation techniques are being explored in university
research and are not commercially available at the present time.
Magnetic separation involves the use of a colliodal suspension of
magnetic particles to which antibodies have been attached. The
magnetic particles surround the cells of interest and subsets of cells
can be separated on the basis of their magnetic properties. Mr.
Barberich suggested that connective forces might limit the use of this
approach in a unit-g environment in a manner that is similar to the
limitations imposed on electrokinetic separation. He contrasted mag-
netic separation to the present techniques used in biotechnology of
attaching the ligand to a solid and then using filtration for separation.
In magnetic separation the ligand would be attracted to a particle in
suspension and magnetic separation would be used to isolate subsets of
cells of interest. This would produce what Mr. Barberich called
magnetic immunsorbants.
(2) Behavior of Immobilized Enzymes in Zero-G.
Enzymes are proteins that serve a catalytic function in a biotechnology
reaction. The enzymes are separated from the reaction broth and are
1 
reused. He suggested that the reaction might be enhanced by zero-G.
If the turnover rate is higher it might be possible to get the same
output with a smaller reactor.
In addition to the foregoing Mr. Barberich said that his company was looking
for technologies that might be useful for biological separation processes. He
asked if it might be possible for him to obtain access to a database that
describes NASA work in this area. Sepracor would be interested in exploring
the possibility of licencing NASA technologies that might be useful in their
work. Mr. Barberich also expressed an interest in obtaining information on
NASA space bioprocessing work in areas that might be applicable to his
interests, and in the availability of NASA hardware that might be used for
coopeative experiments.
4. ACTIONS
(1) Provide a database of NASA space bioprocessing experiments, and in
particular, any experiment that might deal with membranes or
magnetic separation.
(2) Provide a da-'abase of hardware that might be available from NASA for
cooperative experiments.
(3) Put Mr. Barberich in contact with NASA Technology Utilization to
discuss NASA biological separation that might be licenced to Sepracor.
S. CONCLUSION
Mr. Barberich had little prior knowledge about the NASA space bioprocessing
program or about the opportunities for cooperative RECD with NASA. He
suggested several areas of investigation that might be of in«: est to him, but
pointed out that his ability to follow through at this time was limited by a
lack of funds.
!	 ^1
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